Alt ID	Old ID	New ID 	PW ID	Biobank ID	Extracted frozen/fresh	Clinical diagnosis	Pathology diagnosis	2ary diagnosis / comments	Genetic diagnosis	Cohort	Fresh-frozen	FFPE	PFC	SN	other brain areas	other	Age	Sex	Ethinicity	Height	Weight	Age of onset	Disease duration	PMI	Fixation time	PH	Brain weight (gr)	braak tau	amyloid	braak-LB	Thal phase	Fresh frozen	Box no, whole brain	FFPE	Pathology description	Details of pathology	apoE	Fam history of PD	Cause of death	Other diseases	Drugs last year of life	Drugs, unknown time of intake	Available tissue	WES	WGS	WGBS	RNA-Seq	ChIP-Seq	ATAC-Seq	Acetyl-Lysin WB	Histone markers WB	Cell markers WB	non-histone protein acetylation WB	H3K27ac WB for correlation with ChIP-Seq
	O114/14	O14/114	B091	NM-001	frozen	PD	PD			Park West	+	+	+	+		whole brain	86	M				78.2	7.8	30			1562	4	0	6		1	1	1			NA	no			Levodopa, Pramipexole, Bumetanide, Folic acid, Mirtazapine			+		+	+	+		+	+	+	+	+
	O09/14	O14/009	B034	NM-002	frozen	PD	PD			Park West			+	+		whole brain	88	M				76.9	11.1	30			1465	4	C	6		1	1	1			NA	no			Levodopa, Ropinirole, Rivastigmine, Warfarin, Lactulose, Methenamine			+		+	+	+		+	+	+	+	+
	O311/14	O14/311	B029	NM-003	frozen	PD	PD			Park West			+	+		whole brain	82	M				69.9	12.1	46			1590	4	A	6		1	1	1			NA	no			Pramipexole, Levodopa, Folic acid, Solifenacin, Furosemide, Rivastigmine, Bicalutamide			+		+	+	+		+	+	+	+	+
	O29/15	O15/029	B013	NM-004	frozen	PD	PD			Park West			+	+		whole brain	81	F				67.6	13.4	15			1350	3	0	5		1	1	1			NA	no			Carbidopa/Levodopa/Entacapone, Lamotrigine, Salmeterolxinafoat, Allopurinol, Alimemazine, Glimepiride, Travoprost, Dorzolamide/Timolol			+		+	+	+		+	+	+	+	+
	O121/12	O12/121	B043	NM-005	frozen	PD	PD			Park West			+	+		whole brain	69	M				62.6	6.4	57			1570	0	0	4		1	2	1			NA	no			Carbidopa/Levodopa/Entacapone, Pramipexole, Rasagiline, Irbesartan/Hydrochlortiazide			+		+	+	+		+	+	+	+	+
	O08/14	O14/008	B057	NM-006	frozen	PD	PD			Park West			+	+		whole brain	72	M				63.1	8.9	48			1475	3	C	6		1	2	1			NA	no			Carbidopa/Levodopa/e√ântacapone, Rasagiline, Lactulose, Pregabalin, Ibuprofen, Quetiapine, Memantine, Enanton, Sertraline			+		+	+	+		+	+	+	+	+
	O69/15	O15/069	B008	NM-007	frozen	PD	PD			Park West			+	+		whole brain	78	F				66.2	11.8	24			1160	3	B	6		1	2	1			NA	no			Levodopa, Rasagiline, Ropinirole, Rotigotine, Pramipexole, deep brain stimulator (DBS), Acetylsalicyclic acid, Pravastatin, Ramipril, Metformin, Ezetimibe			+		+	+	+		+	+	+	+	+
	O327/14	O14/327	B077	NM-008	frozen	PD	PD			Park West			+	+		whole brain	82	M				71.9	10.1	84			1590	4	0	6		1	2	1			NA	no			Pramipexole, Levodopa, Rasagiline, Acetylsalicyclic acid, Irbesartan, Metoprolol, Atorvastatin, Clopidogrel, Isosorbide mononitrate, Ramipril, Zopiclone, Diazepam			+		+	+	+		+				+
	O74/13	O13/074	B036	NM-009	frozen	PD	PD			Park West			+	+		whole brain	95	M				86.6	8.4	48				NA	NA	NA		1	3	1			NA	yes (1 sibling, possible PD)			Levodopa, Donepezil hydrochloride, Atorvastatin, Metothrexate, Esomeprazole, Folic acid, Paracetamol, Prednisolone, Zopiclone			+		+	+	+		+				+
	O249/15	O15/249	B051	NM-010	frozen	PD	PD			Park West			+	+		whole brain	90	F				80.2	9.8	24			1210	3	0	5		1	3	1			NA	no			Levodopa, Trihexylphenidyl, Zolpidem 			+		+	+	+		+				+
	O354/15	O15/354	B006	NM-011	frozen	PD	PD			Park West			+	+		whole brain	80	F				64.6	15.4	48			1240	3	B	6		1	3	1			NA	no			Levodopa, Pramipexole, Selegiline, Rasagiline, Kliogest, Levothyroxine			+		+	+	+		+				+
	O123/16	O16/123	B090	NM-012	frozen	PD	PD			Park West			+	+		whole brain	72	F				62.4	9.6	72			1430	3	0	6		1	3	1			NA	no			Carbidopa/Levodopa/Entacapone, Pramipexole, Selegiline, Rotigotine, Rasagiline, Sertraline			+		+	+	+		+				+
	O162/16	O16/162	B058	NM-013	frozen	PD	PD			Park West			+	+		whole brain	74	M				61.6	12.4	24				4	C	6		1	4	1			NA	yes (father and 1 sibling, possible PD)			Pramipexole, Paroxetine			+		+	+	+		+				+
	O206/17	O17/206	F24	NM-014	fresh	PD	PD			Park West			+	+		whole brain	69	F				57.5	11.5	30			1465	0-1	B	6		1	4	1			NA	no			levodopa, paracetamol, solifenacin			+		+	+	+						+
	O151/17	O17/151	B99	NM-015	uncertain	PD	PD			Park West			+	+		whole brain	86	F				75.7	10.3	60			1200	2-3	C	6		1	4	1			NA	yes (1 sibling, possible PD)			Levodopa, pramipexole, circadin, vitamin D, magnesium, paracetamol, estriol, tramadol hydrochloride, xerodent, sodium picosulfate, movicol, vitamin B12, salmeterol, hydrocortisone butyr-emollient, ibuprofen			+		+	+	+						+
	O152/17	O17/152	B84	NM-016	uncertain	PD	PD			Park West			+	+		whole brain	85	M				73.6	11.4	33			1245	3	A	6		1	4	1			NA	no			levodopa, vitamin B12, warfarin, escitalpram, simvastatin, pantoprazole, vitamin D			+		+	+	+						+
	O205/17	O17/205	F22	NM-017	fresh	PD	PD			Park West			+	+		whole brain	83	F				68.7	14.3	33			1425	5	C	6		1	5	1			NA	no			levodopa, vitamin C, omeprazole, timolol, paracetamol			+		+	+	+						+
	O065/18	O18/065	B021	NM-018	fresh	PD	PD			Park West			+	+		whole brain	82	M				62.3	19.7	22								1	5	1			NA							+				+						+
	O279/17	O17/279	B094	NM-019	frozen	PD	PD			Park West			+	+		whole brain	75	M				63.6	11.5	?								1	5	1			NA							+				+						+
	O006/18	O18/006	B022	NM-020	fresh	PD	PD			Park West			+	+		whole brain	79	M				66.2	12.8	?								1	5	1			NA							+				+						+
	O069/18	O18/069	B089	NM-021	fresh	PD	PD			Park West			+	+		whole brain	94	M				80.5	13.5	36								1	6	1			NA							+				+						+
STAV 87/16	O18/120	O18/120	S55	NM-022	frozen	PD	PD			Park West			+	+		whole brain	76	F				64.7	11.3	48								1	6	1			NA							+				+						+
STAV 92/17	O18/123	O18/123	S39	NM-023	frozen	PD	PD			Park West			+	+		whole brain	89	M				77.8	11.2	24								1	6	1			NA							+				+						+
STAV 94/18	O18/122	O18/122	S23	NM-024	frozen	PD	PD			Park West			+	+		whole brain	71	M				55.2	15.8	24								1	6	1			NA							+				+						+
STAV 95/18	O18/121	O18/121	S16	NM-025	frozen	PD	PD			Park West			+	+		whole brain	71	M				57.6	13.4	48								1	7	1			NA							+				+						+
STAV 96/18	O18/119	O18/119	S42	NM-026	frozen	PD	PD			Park West			+	+		whole brain	96	F				69.1	26.9	24								1	7	1			NA							+				+						+
	S01/280	S01/280		NM-027	frozen	PD				Netherlands Brain Bank	+		+				86	M				60	26	5.5		6.19	1219	1	O	4		1		0			33	no			levodopa/carbidopa, diclofenac, psyllium seed, paracetamol,  pergolide,  paroxetine, magnesiumoxide, oxazepam, nitrazepam, temazepam, terminafine 					+	+	+						+
	S02/050	S02/050		NM-028	frozen	PD				Netherlands Brain Bank	+		+				84	M				74	10	5		6.8	1183	2	B	5		1		0			33	no			furosemide, fentanyl transdermal, enalapril, temazepam,  levodopa/benserazide, pergolide, oxazepam, spironolactone, fenprocoumar, allopurinol					+	+	+						+
	S06/002	S06/002		NM-029	frozen	PD				Netherlands Brain Bank	+		+				84	F				67	17	7.5		6.85	1229	2	B	5		1		0			33	no			risidronine acid, calciumcarbonaat/colecalciferol, levodopa/benserazide, quetiapine, temazepam, cetirizine, ciprofloxacine, paracetamol					+	+	+						+
	S11/068	S11/068		NM-030	frozen	PD				Netherlands Brain Bank	+		+				80	F				56	24	7		6.5	1265	0	O	4		1		0			43	no			Tolterodine, Levodopa/Benserazide, Pantoprazol, Paracetamol, Levothyroxine, Dilthiazem, Diclophenac, Domperidon, Pramipexol, Levodopa/Carbidopa/entacapon, Nandoparine, Lorazepam , Flucloxalacinne, Oxybutinine 					+	+	+						+
	S11/079	S11/079		NM-031	frozen	PD				Netherlands Brain Bank	+		+				81	M				71	10	4.5		6.42	1315	2	A	6		1		0			33	no			Tramadol,  Levodopa, Benserazide, Pramipexol, Selegiline, Clonazepam, Pantoprazol, Alendronic acid, Calcium carbonate, Paracetamol, Ibuprofen					+	+	+						+
	S13/058	S13/058		NM-032	frozen	PD				Netherlands Brain Bank	+		+				77	F				62	15	7.3		?	1384	1	A	6		1		0			NA	no			Levodopa/Carbidopa/Entacapon, Domperidon, Pramipexol, Clozapine 6.25 mg, Lisinopril, Rivastigmine plaster, Acenocoumarol, Pantoprazol, Temazepam 					+	+	+						+
	S13/091	S13/091		NM-033	frozen	PD				Netherlands Brain Bank	+		+				84	M				78	6	5		6.41	1430	1	A	3		1		0			NA	2 cousins with possible PD			Levodopa/Benserazide, Temazepam, Tamsulosine, Budesonide, Formoterol, Formoterol/beclometason, Salbutamol 					+	+	+						+
	S14/036	S14/036		NM-034	frozen	PD				Netherlands Brain Bank	+		+				75	M				50	25	6		6.54	1455	1	A	6		1		0			NA	no			Fesoterodine, Oxazepam, Loperamide, Zolpidem, Clonazepam, Ferrous fumarate, Duodopa, Fentanyl					+	+	+						+
	S14/061	S14/061		NM-035	frozen	PD				Netherlands Brain Bank	+		+				88	F				67	21	6.5		5.98	1085	3	B	6		1		0			NA	no			Levodopa, Carbidopa, Amantadine, Nitrofurantoin, Isosorbide mononitrate, Fosfomycine, Carbasalate Calcium, Pergolide Mesylate, Lactulose, Lisinopril, Paracetamol, Pantoprazole, Macrogol, Bumetanide, Tramadol, Folic acid					+	+	+						+
	S15/072	S15/072		NM-036	frozen	PD				Netherlands Brain Bank	+		+				75	M				67	8	8.5		6.74	1340	1	O	5		1		0			NA	no			Levodopa/Carbidopa/Entacapon, Enalapril 20 mg, Ventolin flixotide, Naproxen 					+	+	+						+
A2	O148/13	O13/148		NM-037	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	79	M						48			1286					1					NA	no								+	+	+		+	+	+	+	+
A5	O254/13	O13/254		NM-038	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	73	M						100								1					NA	no										+		+	+	+	+	+
A8	O289/13	O13/289		NM-039	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	86	F						72			1280					1					NA	no								+	+	+		+	+	+	+	+
A10	O35/14	O14/35		NM-040	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	87	M						36			1345					1					NA	no								+	+	+		+	+	+	+	+
C5	O75/11	O11/75		NM-041	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	66	F						43								1					NA	no								+	+	+		+	+	+	+	+
C20	C20	C20		NM-042	frozen (I think)	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	63	M						24								1					NA	no								+	+	+		+	+	+	+	+
A11	O58/14	014/58		NM-043	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	87	M						48			1510					1					NA	no								+	+	+		+	+	+	+	+
C21	C21	C21		NM-044	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	63	F						48								1					NA	no								+	+	+		+				+
C1	O248/09	O09/248		NM-045	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	66	M						80			1525					1					NA	no								+	+	+		+				+
A4	O241/13	O13/241		NM-046	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	85	F						72			1260					1					NA	no								+	+	+		+				+
SB1	O284/10	O10/284		NM-047	frozen	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	88	F						48			1115					1	7				NA	no								+	+	+		+				+
A6	O255/13	O13/255		NM-048	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	60	M						90								1					NA	no										+		+				+
A9	O12/14	O12/14		NM-049	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	81	F						100			1140					1					NA	no										+		+				+
C2	O203/10	O10/203		NM-050	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	65	M						48			1460					1					NA	no								+	+	+						+
	R269/13	R13/269		NM-051	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	52	M						24								1					NA	no										+						+
	O176/13	O13/176		NM-052	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	62.6	M						48								1					NA	no										+						+
	O68/14	O14/68		NM-053	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	59	F						48								1					NA	no										+						+
	R89/14	R14/89		NM-054	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	55	M						48								1					NA	no										+						+
	O30/18	O18/30		NM-055	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	96	F						24								1	7				NA	no										+						+
	R90/14	R14/90		NM-056	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	56	M						72								1					NA	no										+						+
	O223/11	O11/223		NM-057	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	56	F						30								1					NA	no										+						+
	O105/18	O18/105		NM-058	fresh	Control	Control			Neuromics Tissue Bank	+	+	+	+		whole brain	78	F						42								1	8				NA	no										+						+
	S11/021	S11/021		NM-059	frozen	Control	Control			Netherlands Brain Bank	+		+				85	F						7		?	1007	1	B	0		1		0			32	no								+	+	+						+
	S11/059	S11/059		NM-060	frozen	Control	Control			Netherlands Brain Bank	+		+				84	F						6		7.65	1266	2	B	0		1		0			33	no								+	+	+						+
	S11/072	S11/072		NM-061	frozen	Control	Control			Netherlands Brain Bank	+		+				76	F						7		6.87	1072	2	O	0		1		0			33	no								+	+	+						+
	S12/001	S12/001		NM-062	frozen	Control	Control			Netherlands Brain Bank	+		+				89	F						5.7		6.75	943	2	B			1		0			NA	no								+	+	+						+
	S12/067	S12/067		NM-063	frozen	Control	Control			Netherlands Brain Bank	+		+				102	M						5		6.64	1124	3	A			1		0			43	no								+	+	+						+
	S12/090	S12/090		NM-064	frozen	Control	Control			Netherlands Brain Bank	+		+				91	F						4		6.58	1052	3	A			1		0			43	no								+	+	+						+
	S12/118	S12/118		NM-065	frozen	Control	Control			Netherlands Brain Bank	+		+				96	M						4		6.09	1250	4	B			1		0			33	no								+	+	+						+
	S13/056	S13/056		NM-066	frozen	Control	Control			Netherlands Brain Bank	+		+				95	M						7		6.56	1387	2	B	1		1		0			42	no								+	+	+						+
	S14/029	S14/029		NM-067	frozen	Control	Control			Netherlands Brain Bank	+		+				78	F						7		6.32	1120	1	A	0		1		0			33	no								+	+	+						+
	S15/033	S15/033		NM-068	frozen	Control	Control			Netherlands Brain Bank	+		+				93	M						7.7		6.2	1155	0	A			1		0			NA	no								+	+	+						+
	S15/035	S15/035		NM-069	frozen	Control	Control			Netherlands Brain Bank	+		+				73	M						8		5.37	1553	2	A			1		0			33	no								+	+	+						+
	1263	1263		NM-070		Thalamic dementia, possible PSP				Barcelona Brain Bank	+		+				63	F						8.17								1		0	CBD, AGD, AD (A3B2C2, BRAAK III, Thal 5, CERAD moderate, moderate CAA), HS		NA																	
	1508	1508		NM-071		RBD		REM sleep alteration		Barcelona Brain Bank	+		+				83	M						4.25								1		0	PD (Braak 5, McKeith neocortical), AD (A3B2C2, BRAAK III-IV, Thal 5, CERAD moderate, sparse and focalised CAA (cerebellum)		NA																	
	1605	1605		NM-072		RBD		REM sleep alteration		Barcelona Brain Bank	+		+				77	M						7								1		0	PD (Braak 4, McKeith limbic), AD (A1B2C0, BRAAK III, Thal 2, CERAD none), AGD II		NA																	
	1610	1610		NM-073		PSP, PD, dementia				Barcelona Brain Bank	+		+				71	F						4.75								1		0	CBD		NA																	
	1773	1773		NM-074		PSP vs MSA				Barcelona Brain Bank	+		+				70	F						15.5								1		0	CBD, AGD I, subacute bacterial meningitis		NA																	
	1528	1528		NM-075		PSP vs hereditary leucodystrophy				Barcelona Brain Bank	+		+				64	M						18.5								1		0	PD (Braak 6, neocortical), AD (A3B3C3, BRAAK V, Thal 5, CERAD frequent)		NA																	
	1793	1793		NM-076		PSP vs CBD				Barcelona Brain Bank	+		+				80	F						14.5								1		0	PSP, AD (A2B1C2, BRAAK II, Thal 3, CERAD moderate), LBD (Braak 4, limbic), SVD with microinfarcts (posterior cingulate, basal ganglia)		NA																	
	1813	1813		NM-077		PSP vs CBD				Barcelona Brain Bank	+		+				85	F						5.5								1		0	PSP, AGD II		NA																	
	1731	1731		NM-078		PSP + vascular				Barcelona Brain Bank	+		+				82	M						13.5								1		0	PSP, AD (A2B1C2, BRAAK II, Thal 3, CERAD moderate), SVD		NA																	
	1306	1306		NM-079		PSP - SD Richardson				Barcelona Brain Bank	+		+				67	M						5								1		0	PSP with coiled bodies		NA																	
	1244	1244		NM-080		PSP		 vascular parkinsonism		Barcelona Brain Bank	+		+				86	F						16								1		0	PD (LBD, Braak 6, McKeith neocortical), AD (A0B2C0, BRAAK III, Thal 0, CERAD none)		NA																	
	1147	1147		NM-081		PSP				Barcelona Brain Bank	+		+				54	F						5.5								1		0	PSP, AD (A1B1C0, BRAAK I, Thal 2, CERAD none)		NA																	
	1150	1150		NM-082		PSP				Barcelona Brain Bank	+		+				64	M						13								1		0	PSP, AD (A1B1C1, BRAAK I, Thal 1, CERAD sparse), PD (Braak 2, brainstem)		NA																	
	1199	1199		NM-083		PSP				Barcelona Brain Bank	+		+				78	M						6.58								1		0	PSP		NA																	
	1259	1259		NM-084		PSP				Barcelona Brain Bank	+		+				78	M						2.5								1		0	PSP, AD (A3B1C2, BRAAK II, Thal 4, CERAD moderate, sparse CAA)		NA																	
	1268	1268		NM-085		PSP				Barcelona Brain Bank	+		+				66	M						6.5								1		0	PSP		NA																	
	1354	1354		NM-086		PSP				Barcelona Brain Bank	+		+				83	F						14.42								1		0	PSP, AGD II		NA																	
	1358	1358		NM-087		PSP		 memory alteration		Barcelona Brain Bank	+		+				82	M						10								1		0	PSP, AD (A3B2C2, BRAAK III, Thal 5, CERAD moderate, moderate CAA), subacute hematoma		NA																	
	1368	1368		NM-088		PSP		behavioral alterations		Barcelona Brain Bank	+		+				77	F						4.75								1		0	PSP, Lacunar infarcts (caudate, thalamus, amygdala), cribosus status		NA																	
	1371	1371		NM-089		PSP				Barcelona Brain Bank	+		+				81	F						8.5								1		0	PSP, possible PART (A1B0C0, BRAAK 0, Thal 1, CERAD none)		NA																	
	1433	1433		NM-090		PSP				Barcelona Brain Bank	+		+				84	F						12.25								1		0	PSP, TFLD-MND-TDP43, possible PART (A1B0C1, BRAAK 0, Thal 2, CERAD sparse)		NA																	
	1437	1437		NM-091		PSP				Barcelona Brain Bank	+		+				81	F						5								1		0	PSP + definite PART (A0B1C0, BRAAK II, Thal 0, CERAD none), PD (Braak 2, brainstem)		NA																	
	1472	1472		NM-092		PSP				Barcelona Brain Bank	+		+				76	M						6.17								1		0	PSP, diffuse beta-amyloid plaques, LBD (Braak 1, brainstem)		NA																	
	1473	1473		NM-093		PSP				Barcelona Brain Bank	+		+				86	F						4								1		0	PSP-P, AGD II, definite PART (A0B1C0, BRAAK II, Thal 0, CERAD none), contusion frontal pole		NA																	
	1496	1496		NM-094		PSP				Barcelona Brain Bank	+		+				61	F						7								1		0	PSP, AGD I		NA																	
	1567	1567		NM-095		PSP				Barcelona Brain Bank	+		+				85	F						6.5								1		0	PSP, definite PART (A0B1C0, BRAAK II, Thal 0, CERAD none)		NA																	
	1652	1652		NM-096		PSP				Barcelona Brain Bank	+		+				83	M						7.25								1		0	PSP, AD (A2B1C2, BRAAK I, Thal 3, CERAD moderate), microinfarct right amygdala		NA																	
	1729	1729		NM-097		PSP				Barcelona Brain Bank	+		+				64	F						12								1		0	PSP, pituitary adenoma		NA																	
	1746	1746		NM-098		PSP				Barcelona Brain Bank	+		+				80	F						3.5								1		0	PSP, LBD (Braak 1, brainstem), pituitary adenoma		NA																	
	1816	1816		NM-099		PSP				Barcelona Brain Bank	+		+				75	F						14								1		0	PSP, AGD II, possible PART (A1B1C0, BRAAK II, Thal 1, CERAD none), severe SVD		NA																	
	1817	1817		NM-100		PSP				Barcelona Brain Bank	+		+				69	F						6								1		0	PSP, possible PART (A1B1C0, BRAAK II, Thal 1, CERAD none), SVD		NA																	
	1821	1821		NM-101		PSP				Barcelona Brain Bank	+		+				81	F						4								1		0	PSP, AGD I, AD (A3B2C2, BRAAK III, Thal 5, CERAD moderate, sparse CAA), meningoethelial meningeoma (stage I)		NA																	
	1832	1832		NM-102		PSP				Barcelona Brain Bank	+		+				69	M						5.25								1		0	PSP, moderate beta-amyloid plaques		NA																	
	1855	1855		NM-103		PSP				Barcelona Brain Bank	+		+				N/A	F						6								1		0	PSP, AD (A3B2C2, BRAAK III, Thal 4, CERAD moderate, sparse CAA), TDP-43 (hippocampus)		NA																	
	1902	1902		NM-104		PSP				Barcelona Brain Bank	+		+				68	F						4.5								1		0	PSP		NA																	
	1923	1923		NM-105		PSP				Barcelona Brain Bank	+		+				70	F						10.5								1		0	PSP, AD (A2B1C1, BRAAK I-II, Thal 3, CERAD sparse)		NA																	
	1738	1738		NM-106		PSP				Barcelona Brain Bank	+		+				74	M						9								1		0	CBD, AD (A3B2C2, BRAAK III, Thal 5, CERAD moderate, sparse CAA), SVD (basal ganglia and pons)		NA																	
	491	491		NM-107		Pick's disease				Barcelona Brain Bank	+		+				68	M						7								1		0	CBD more than PSP		NA																	
	755	755		NM-108		PDD (LRRK2)			LRRK2: p.G2019S	Barcelona Brain Bank	+		+				77	F						8								1		0	AD (A0B2C0, BRAAK III, Thal 0, CERAD none) SVD, Lacunar infarct (head of nucleus caudatus)		NA																	
	988	988		NM-109		PDD				Barcelona Brain Bank	+		+				84	M						7								1		0	PD (Braak 5-6, neocortical) AD (A0B2C0, BRAAK III, Thal 0, CERAD none)		NA																	
	1006	1006		NM-110		PDD				Barcelona Brain Bank	+		+				83	M						7.5								1		0	PD (Braak 5, neocortical), AD (A2B2C3, BRAAK III-IV, Thal 3, CERAD frequent)		NA																	
	1082	1082		NM-111		PDD				Barcelona Brain Bank	+		+				80	M						7.5								1		0	PD (Braak 6, neocortical), AD (A3B2C3, BRAAK III, Thal 5, CERAD frequent, sparse CAA), TDP-43 (amygdala)		NA																	
	1116	1116		NM-112		PDD				Barcelona Brain Bank	+		+				81	F						12.5								1		0	PD (Braak 6, neocortical), AD (A3B2C3, BRAAK III, Thal 5, CERAD frequent, sparse CAA)		NA																	
	1210	1210		NM-113		PDD				Barcelona Brain Bank	+		+				85	M						12.25								1		0	PD (Braak 5, neocortical), moderate beta-amyloid plaques		NA																	
	1224	1224		NM-114		PDD				Barcelona Brain Bank	+		+				82	M						7.25								1		0	PD (Braak 4-5, McKeith neocortical), AGD III, NFT IV, SVD		NA																	
	1238	1238		NM-115		PDD				Barcelona Brain Bank	+		+				76	M						17.08								1		0	PD (LBD, Braak 5, McKeith limbic), AD (A0B2C2, BRAAK IV, Thal 0, CERAD moderate CAA)		NA																	
	1275	1275		NM-116		PDD				Barcelona Brain Bank	+		+				81	M						5								1		0	PD (Braak 5, neocortical), A3B2C2 (BRAAK IV, Thal 4, CERAD moderate) HBV		NA																	
	1317	1317		NM-117		PDD				Barcelona Brain Bank	+		+				75	M						24								1		0	PD (Braak 4, McKeith limbic), AD (A1B2C1, BRAAK IV, Thal 2, CERAD sparse), Multiple sclerosis		NA																	
	1363	1363		NM-118		PDD				Barcelona Brain Bank	+		+				75	F						7								1		0	PD (LBD, Braak 6, McKeith neocortical), AD (A1B2C2, BRAAK IV, Thal 1, CERAD moderate, sparse CAA)		NA																	
	1364	1364		NM-119		PDD				Barcelona Brain Bank	+		+				80	F						5								1		0	PD (Braak 5, McKeith neocortical), A1B1C2 (Braak II, Thal 2, CERAD moderate), Pick's disease phenotype, SVD		NA																	
	1484	1484		NM-120		PDD				Barcelona Brain Bank	+		+				87	M						15.25								1		0	PD (Braak 5, McKeith limbic), AD (A2B1C1, BRAAK II, Thal 3, CERAD sparse)		NA																	
	1575	1575		NM-121		PDD				Barcelona Brain Bank	+		+				71	M						5								1		0	LBD vs PD (Braak 4, limbic) Low AD (A2B1C2, BRAAK I, Thal 3), teleangiectasia		NA																	
	1626	1626		NM-122		PDD				Barcelona Brain Bank	+		+				83	F						4								1		0	PD (Braak 4-5, limbic) AD (BRAAK II, Thal 2, CERAD sparse)		NA																	
	1701	1701		NM-123		PDD				Barcelona Brain Bank	+		+				62	M						13.5								1		0	PD (Braak 5, McKeith neocortical), low AD (A2B1C1, BRAAK II, Thal 3, CERAD sparse)		NA																	
	1775	1775		NM-124		PDD				Barcelona Brain Bank	+		+				72	M						6								1		0	PD (Braak 6, neocortical), A3B2C2, BRAAK II, Thal 4, CERAD moderate, sparse CAA + acute microinfarct (cerebral artery)		NA																	
	1777	1777		NM-125		PDD				Barcelona Brain Bank	+		+				90	F						5.5								1		0	PD (Braak 4, McKeith limbic), AD (A2B2C1, BRAAK III, Thal 3, CERAD sparse)		NA																	
	1972	1972		NM-126		PDD				Barcelona Brain Bank	+		+				75	M						17.75								1		0	PD (LBD, Braak 6, McKeith neocortical), PSP williams 6-7, AD (A1B1C1, BRAAK II, Thal 2), adenoma HF LH		NA																	
	1831	1831		NM-127		PDD				Barcelona Brain Bank	+		+				83	M						5								1		0	PSP, AGD, AD (A2B2C2, BRAAK III, Thal 5, CERAD moderate, sparse CAA, vascular pathology with microinfarct (motor cortex)		NA																	
	636	636		NM-128		PD (LRRK2)			LRRK2: p.G2019S	Barcelona Brain Bank	+		+				78	F						27.5								1		0	PD (Braak 4, McKeith limbic)		NA																	
	953	953		NM-129		PD (LRRK2)			LRRK2: p.G2019S	Barcelona Brain Bank	+		+				92	F						7								1		0	PD (Braak 4, limbic) AD (A3B2C3, BRAAK IV, Thal 5, CERAD frequent, moderate CAA), Lacunar infarct (occipital lobe), demyelination of white matter in parietal and temporl lobes		NA																	
	1565	1565		NM-130		PD (LRRK2)			LRRK2: p.G2019S	Barcelona Brain Bank	+		+				69	F						12.5								1		0	PD (Braak 5, McKeith neocortical), DBS, AD (A3B1C2, BRAAK II, Thal 4, CERAD moderate), SVD		NA																	
	1826	1826		NM-131		PD (LRRK2)			LRRK2: p.R1441H	Barcelona Brain Bank	+		+				69	M						15.5								1		0	moderate degeneration of SN without LB, SVD		NA																	
	1837	1837		NM-132		PD (LRRK2)			LRRK2: p.G2019S	Barcelona Brain Bank	+		+				85	M						17								1		0	PSP, AD (A3B2C2, BRAAK III, Thal 4, CERAD moderate)		NA																	
	347	347		NM-133		PD				Barcelona Brain Bank	+		+				69	F						4.5								1		0	PD (Braak 4, McKeith limbic)		NA																	
	416	416		NM-134		PD				Barcelona Brain Bank	+		+				81	M						5.5								1		0	Not classificable		NA																	
	574	574		NM-135		PD				Barcelona Brain Bank	+		+				79	F						3.5								1		0	PD (Braak 4, McKeith limbic), possible PART (A1B1C2, BRAAK I, Thal 1, CERAD moderate)		NA																	
	616	616		NM-136		PD				Barcelona Brain Bank	+		+				76	M						15.5								1		0	PD + AD (AXB2CX, BRAAK III-IV, Thal X, CERAD none)		NA																	
	656	656		NM-137		PD				Barcelona Brain Bank	+		+				81	F						19								1		0	PD (Braak 4, McKeith limbic) + lacunar infarcts (putamen, pallidus, thalamus and white matter of frontal lobe) + definite PART (A0B1C0, BRAAK II, Thal 0, CERAD none)		NA																	
	686	686		NM-138		PD				Barcelona Brain Bank	+		+				73	M						3.5								1		0	PD (Braak 4-5) + AD (A0B1C0, BRAAK I, Thal 0, CERAD none)		NA																	
	848	848		NM-139		PD				Barcelona Brain Bank	+		+				74	M						5.5								1		0	PD (Braak 4, McKeith limbic)+ multiple hemorrhagic infarcts (cortex, caudate, putamen and pons)		NA																	
	902	902		NM-140		PD				Barcelona Brain Bank	+		+				83	M						14								1		0	PD (LBD, Braak 5, McKeith limbic), AD (A0B1C0, BRAAK II, Thal 0, CERAD none)		NA																	
	930	930		NM-141		PD				Barcelona Brain Bank	+		+				88	M						16.5								1		0	PD (Braak 4, limbic), AD (A2B2C1, BRAAK III, Thal 3, CERAD sparse)		NA																	
	962	962		NM-142		PD				Barcelona Brain Bank	+		+				85	F						7								1		0	PD (Braak 5, McKeith limbic), AD (A0B2C0, BRAAK IV, Thal 0, CERAD none), Lacunar infarct (striatum)		NA																	
	1027	1027		NM-143		PD				Barcelona Brain Bank	+		+				77	F						7.5								1		0	PD (Braak 5, neocortical), possible PART (A1B1C1, BRAAK II, Thal 1, CERAD sparse, moderate CAA), left subacute infarcts (frontal and parietal lobes, putamen, inner capsule)		NA																	
	1094	1094		NM-144		PD				Barcelona Brain Bank	+		+				80	M						6.42								1		0	PD (Braak 4, neocortical), AD (AXB2C1, BRAAK III, Thal X, CERAD sparse)		NA																	
	1100	1100		NM-145		PD				Barcelona Brain Bank	+		+				76	M						12								1		0	PD (LBD, Braak 5, McKeith limbic), AD (A1B1C3, BRAAK II, Thal 1, CERAD frequent)		NA																	
	1105	1105		NM-146		PD				Barcelona Brain Bank	+		+				88	F						7								1		0	PD (LBD, Braak 5, McKeith neocortical), AGD III		NA																	
	1157	1157		NM-147		PD				Barcelona Brain Bank	+		+				84	F						4.5								1		0	PD (Braak 4, limbic)		NA																	
	1181	1181		NM-148		PD		VHC+		Barcelona Brain Bank	+		+				81	F						6.5								1		0	PD (Braak 4, limbic), NFT III		NA																	
	1182	1182		NM-149		PD				Barcelona Brain Bank	+		+				68	M						9.5								1		0	PD (Braak 4)		NA																	
	1226	1226		NM-150		PD		frontal dementia		Barcelona Brain Bank	+		+				80	M						7.5								1		0	PD (Braak 4, McKeith limbic) DBS		NA																	
	1245	1245		NM-151		PD				Barcelona Brain Bank	+		+				81	F						13.25								1		0	PD (Braak 4, McKeith limbic), AD (A3B1C2, BRAAK I, Thal 5, CERAD moderate)		NA																	
	1246	1246		NM-152		PD				Barcelona Brain Bank	+		+				69	F						5								1		0	PD (Braak 4, McKeith limbic), AGD III		NA																	
	1252	1252		NM-153		PD				Barcelona Brain Bank	+		+				79	M						11								1		0	PD (LBD, Braak 3, McKeith limbic), AD (A0B1C0, BRAAK II, Thal 0; CERAD none)		NA																	
	1318	1318		NM-154		PD		VHB+		Barcelona Brain Bank	+		+				50	M						16.25								1		0	PD (Braak 5, McKeith neocortical), DBS, hypoxic-ischemic damage (cerebellum)		NA																	
	1332	1332		NM-155		PD		long-standing disease		Barcelona Brain Bank	+		+				81	M						5								1		0	PD (LBD, Braak 5, McKeith neocortical) AGD I		NA																	
	1376	1376		NM-156		PD		cognitive impairment and RBD		Barcelona Brain Bank	+		+				77	M						4								1		0	PD (Braak 4, limbic), AD (A1B1C1, BRAAK II, Thal 1, CERAD sparse)		NA																	
	1397	1397		NM-157		PD		arnold chiari		Barcelona Brain Bank	+		+				78	F						18								1		0	PD (Braak 5, neocortical), early PSP, diffuse hypoxia		NA																	
	1424	1424		NM-158		PD				Barcelona Brain Bank	+		+				74	M						8								1		0	PD (Braak 5, McKeith neocorical), AD (A3B2C2, braak III, Thal 5, CAA moderate (MOD)), ARP III		NA																	
	1613	1613		NM-159		PD				Barcelona Brain Bank	+		+				74	M						14.08								1		0	PD (Braak 5, McKeith neocortical) DBS		NA																	
	1617	1617		NM-160		PD				Barcelona Brain Bank	+		+				81	M						7.33								1		0	PD (Braak 4-5, limbic), AD (A3B1C1, BRAAK II, Thal 4, Cerad sparse)		NA																	
	1676	1676		NM-161		PD				Barcelona Brain Bank	+		+				80	M						16.5								1		0	PD (Braak 4, limbic), AD (A0B1C0, BRAAK II, Thal 0, CERAD none)		NA																	
	1705	1705		NM-162		PD				Barcelona Brain Bank	+		+				92	M						16.67								1		0	PD (Braak 4-5, limbic), AD (A1B2C1m BRAAK III, Thal 2, CERAD sparse)		NA																	
	1786	1786		NM-163		PD		 late dementia		Barcelona Brain Bank	+		+				69	F						11								1		0	PD (Braak 4, limbic), AD (A2B2C1, BRAAK III, Thal 3, CERAD sparse)		NA																	
	1820	1820		NM-164		PD				Barcelona Brain Bank	+		+				83	M						11								1		0	PD (Braak 4, limbic) AD (A1B1C2, BRAAK I-II, Thal 2, CERAD moderate)		NA																	
	1893	1893		NM-165		PD				Barcelona Brain Bank	+		+				65	M						18.75								1		0	PD (Braak 4, McKeith limbic), PART DEF, ARTAG (TSA amygdala subependymal)		NA																	
	1985	1985		NM-166		PD		narcolepsy		Barcelona Brain Bank	+		+				84	M						5.42								1		0	PD (Braak 6, McKeith neocortical) AD (A3B2C1, Thal 5, BRAAK IV, CAA), ARTAG, SCD lacunar, narcolepsy		NA																	
	967	967		NM-167		PD				Barcelona Brain Bank	+		+				79	F						10								1		0	MSA, NFT II		NA																	
	1303	1303		NM-168		parkinsonism (atypical)				Barcelona Brain Bank	+		+				76	M						4								1		0	PD (Braak 4, McKeith limbic), NFT I-II		NA																	
	1709	1709		NM-169		Parkinsonism  (atypical), progressive aphasia,				Barcelona Brain Bank	+		+				83	M						7								1		0	CBD, AGD, SVD with lacunar infarcts (basal ganglia)		NA																	
	1600	1600		NM-170		parkinsonism + cerebellar syndrome				Barcelona Brain Bank	+		+				86	F						5								1		0	PSP, AD (A3B1C2, BRAAK II, Thal 4, CERAD moderate)		NA																	
	506	506		NM-171		Parkinsonism				Barcelona Brain Bank	+		+				70	F						4.5								1		0	PD (Braak 3-4, McKeith limbic)		NA																	
	481	481		NM-172		MSA-p				Barcelona Brain Bank	+		+				68	F						9.5								1		0	MSA-SND (stage II-III), OPCA (stage I), NO AD pathology (A0B0C0)		NA																	
	519	519		NM-173		MSA-p				Barcelona Brain Bank	+		+				49	M						12								1		0	MSA-SND (stage II), OPCA (stage II)		NA																	
	587	587		NM-174		MSA-p				Barcelona Brain Bank	+		+				69	F						6								1		0	MSA-SND (stage III), OPCA (stage II), PART (A0B1C0, BRAAK II, Thal 0, CERAD 0)		NA																	
	733	733		NM-175		MSA-p				Barcelona Brain Bank	+		+				59	M						18								1		0	MSA-SND (stage III), OPCA (stage I)		NA																	
	756	756		NM-176		MSA-p				Barcelona Brain Bank	+		+				52	F						5.5								1		0	MSA-SND (stage III), OPCA (stage II-III)		NA																	
	829	829		NM-177		MSA-p				Barcelona Brain Bank	+		+				59	M						4.5								1		0	MSA-SND (stage III), OPCA (stage II)		NA																	
	859	859		NM-178		MSA-p				Barcelona Brain Bank	+		+				58	F						11								1		0	MSA-SND (stage III), OPCA (stage II)		NA																	
	886	886		NM-179		MSA-p				Barcelona Brain Bank	+		+				66	F						15								1		0	MSA, NFT II		NA																	
	893	893		NM-180		MSA-p				Barcelona Brain Bank	+		+				68	F						22.5								1		0	MSA, AD (A1B1C1, BRAAK I, Thal 1, CERAD sparse)		NA																	
	1045	1045		NM-181		MSA-p				Barcelona Brain Bank	+		+				59	F						6.17								1		0	MSA-SND (stage II-III), OPCA (stage I)		NA																	
	1341	1341		NM-182		MSA-p				Barcelona Brain Bank	+		+				73	M						10.5								1		0	MSA-SND (stage III), OPCA (stage II), AGD II, low AD pathology (AUKB1C1, BRAAK I, Cerad A, thal uk)		NA																	
	1578	1578		NM-183		MSA-p		RBD		Barcelona Brain Bank	+		+				51	F						5.75								1		0	MSA-SND (stage III), OPCA (stage II)		NA																	
	1657	1657		NM-184		MSA-p				Barcelona Brain Bank	+		+				62	M						18.5								1		0	MSA-SND (stage III), OPCA (stage III), AD  (A2B1C2, BRAAK I, Thal 3, CERAD moderate)		NA																	
	1678	1678		NM-185		MSA-p		RBD, VHC+		Barcelona Brain Bank	+		+				55	M						12.42								1		0	MSA-SND (not classicable), OPCA (stage III), VHC		NA																	
	1682	1682		NM-186		MSA-p				Barcelona Brain Bank	+		+				71	M						8								1		0	MSA-SND (stage III), OPCA (stage I-II), low AD (A1B1C0 VS 1, BRAAK II, Thal 1, CERAD OVSA)		NA																	
	1790	1790		NM-187		MSA-p				Barcelona Brain Bank	+		+				63	F						14.58								1		0	MSA-SND (stage II), OPCA (stage III), AD (A1B1C1, BRAAK I, Thal 2, CERAD sparse), infarct insula		NA																	
	1892	1892		NM-188		MSA-p				Barcelona Brain Bank	+		+				68	F						12								1		0	MSA-SND (stage II-III), OPCA (stage III), AD  (A1B1C0, BRAAK I, Thal 2, CERAD none)		NA																	
	786	786		NM-189		MSA-c				Barcelona Brain Bank	+		+				60	M						11								1		0	MSA-SND (stage I), OPCA (stage I-II)		NA																	
	1373	1373		NM-190		MSA-c				Barcelona Brain Bank	+		+				66	F						6								1		0	MSA-SND (stage II), OPCA (stage III)		NA																	
	1428	1428		NM-191		MSA-c				Barcelona Brain Bank	+		+				71	M						4.75								1		0	MSA-SND (stage II), OPCA (stage III), NFT III		NA																	
	1474	1474		NM-192		MSA-c				Barcelona Brain Bank	+		+				74	F						5								1		0	MSA-SND (stage II), OPCA (stage III), AD  (A2B1C1, BRAAK I-II, Thal 3, CERAD sparse)		NA																	
	1641	1641		NM-193		MSA-c		RBD		Barcelona Brain Bank	+		+				58	M						14.75								1		0	MSA-SND (stage II), OPCA (stage III), NFT III		NA																	
	1799	1799		NM-194		MSA-c				Barcelona Brain Bank	+		+				66	F						4.5								1		0	MSA-SND (stage III), OPCA (stage III), atypical dentate gyrus anular inclusions		NA																	
	1782	1782		NM-195		MSA vs PSP vs CBD vs atypical parkinsonism				Barcelona Brain Bank	+		+				74	M						5.75								1		0	PSP, AGD III, AD (A2B1C1, BRAAK II, Thal 3, CERAD sparse, sparse CAA)		NA																	
	556	556		NM-196		MSA vs PSP				Barcelona Brain Bank	+		+				82	M						15.5								1		0	PSP, CBD		NA																	
	314	314		NM-197		MSA				Barcelona Brain Bank	+		+				68	M						4								1		0	MSA-SND (stage II), OPCA (stage I)		NA																	
	389	389		NM-198		MSA				Barcelona Brain Bank	+		+				61	F						12.5								1		0	MSA-SND (stage II-III, SN more than BG), OPCA (stage III)		NA																	
	1136	1136		NM-199		MSA				Barcelona Brain Bank	+		+				65	F						6.5								1		0	MSA-SND (stage II), OPCA (stage I), NO AD pathology		NA																	
	1950	1950		NM-200		MSA				Barcelona Brain Bank	+		+				67	M						16.5								1		0	MSA-SND (stage I), OPCA (stage III), AD (A3B1C2, BRAAK I, Thal 4, CERAD moderate), SVD		NA																	
	1975	1975		NM-201		MSA				Barcelona Brain Bank	+		+				55	F						9.75								1		0	MSA (OPCA II-III, SND II-III), AD (A2B1C1, BRAAK II, Thal 3, CAA), ARTAG		NA																	
	2022	2022		NM-202		MSA				Barcelona Brain Bank	+		+				64	F						3.67								1		0	MSA-SND (stage II-III), OPCA (stage III), AD (A1B1C0, BRAAK I, Thal 2, CERAD none), moderate arteriosclerosis and intraparenchimal arteriohialinosis		NA																	
	1191	1191		NM-203		limbic encephalitis				Barcelona Brain Bank	+		+				81	M						4.42								1		0	PD (Braak 6, neocortical), AD (A3B2C2, BRAAK III, Thal 5, CERAD moderate)		NA																	
	1440	1440		NM-204		LBD vs PD vs tauopathy				Barcelona Brain Bank	+		+				84	M						6.5								1		0	PSP MOD, AGD III, vascular encephalopathy with multiple microinfartcs (basal ganglia and white matter), AD (A3B2C2, BRAAK III, Thal 4, CERAD moderate)		NA																	
	938	938		NM-205		LBD				Barcelona Brain Bank	+		+				80	M						9.67								1		0	PD (Braak 5, McKeith neocortical), A3B2C2 (BRAAK IV, Thal 4, CERAD moderate, sparse CAA), SVD		NA																	
	1670	1670		NM-206		LBD				Barcelona Brain Bank	+		+				75	F						3.75								1		0	PD (Braak 5, neocortical), AD (A0B1C0, BRAAK II, Thal 0, CERAD none)		NA																	
	1170	1170		NM-207		LBD				Barcelona Brain Bank	+		+				69	M						7								1		0	PSP		NA																	
	790	790		NM-208		LBD				Barcelona Brain Bank	+		+				74	M						8.75								1		0	MSA, AD (A3B3C3, BRAAK V, Thal 5, CERAD severe, sparse CAA)		NA																	
	549	549		NM-209		LBD				Barcelona Brain Bank	+		+				70	M						15								1		0	CBD, AD (A3B2C3, BRAAK IV, Thal 4, CERAD frequent, moderate CAA), LBD (olfactory bulb only)		NA																	
	1748	1748		NM-210		FTLD, cognitive impariment				Barcelona Brain Bank	+		+				79	F						13.5								1		0	PSP, AD (A2B1C2, BRAAK II, Thal 3, CERAD moderate, moderate CAA), SVD		NA																	
	1592	1592		NM-211		FTD, Pick's disease (progressive aphasia, behavioural alteration)				Barcelona Brain Bank	+		+				64	M						7.5								1		0	CBD, diffuse beta-amyloid plaques		NA																	
	1359	1359		NM-212		FTD vs progressive aphasia				Barcelona Brain Bank	+		+				67	F						6.75								1		0	CBD with moderate beta-amyloid plaques and isolated TDP43)		NA																	
	697	697		NM-213		FTD				Barcelona Brain Bank	+		+				75	M						10.17								1		0	CBD, AGD I		NA																	
	1779	1779		NM-214		FTD				Barcelona Brain Bank	+		+				82	F						16								1		0	CBD, AGD II, isolated TDP43, definite PART (A0B1C0, BRAAK II, Thal 0, CERAD none)		NA																	
	1751	1751		NM-215		early onset AD				Barcelona Brain Bank	+		+				59	M						7								1		0	CBD		NA																	
	361	361		NM-216		dementia				Barcelona Brain Bank	+		+				86	F						20								1		0	CBD, LBD (Braak 3, brainstem), AD (A3B1C2, BRAAK II, Thal 3, CERAD moderate)		NA																	
	497	497		NM-217		Control				Barcelona Brain Bank	+		+				82	M						2.5								1		0	AD (A1B2C2, BRAAK IV, Thal 1, CERAD moderate)		NA																	
	1074	1074		NM-218		Control				Barcelona Brain Bank	+		+				31	M						17.5								1		0	No histological changes		NA																	
	1468	1468		NM-219		Control				Barcelona Brain Bank	+		+				64	M						10								1		0	LBD (Braak 1, olfactory bulb only), possible PART (AD A1B1C1, BRAAK II, Thal 2, CERAD A)		NA																	
	1541	1541		NM-220		Control				Barcelona Brain Bank	+		+				56	F						14								1		0	AD (A1B1C0, BRAAK I-II, Thal 1, CERAD none) NFT I-II, cerebral metastasis (putamen, cerebellum)		NA																	
	1557	1557		NM-221		Control				Barcelona Brain Bank	+		+				86	M						10.25								1		0	LBD (Braak 3, brainstem), definite PART-AD (A0B2C0, BRAAK II, Thal , CERAD none, moderate CAA)		NA																	
	1679	1679		NM-222		Control		brainstem hemorrhage		Barcelona Brain Bank	+		+				90	F						13.67								1		0	brainstem hemorrhage, AD (A2B2C2, BRAAK III, Thal 3, CERAD moderate), limbic TDP43 (CA1)		NA																	
	1697	1697		NM-223		Control		EPOC		Barcelona Brain Bank	+		+				78	M						6								1		0	definite PART (A0B1C0, BRAAK I-II, Thal 0, CERAD 0), LBD (Braak 1, brainstem), lacune infarct (putamen)		NA																	
	1733	1733		NM-224		Control				Barcelona Brain Bank	+		+				76	M						11.5								1		0	AGD I		NA																	
	1752	1752		NM-225		Control		HTA		Barcelona Brain Bank	+		+				88	F						24								1		0	AGD II, low AD (A2B1C2, BRAAK II, Thal 3, CERAD moderate, moderate CAA)		NA																	
	1858	1858		NM-226		Control				Barcelona Brain Bank	+		+				83	F						7.5								1		0	Definite PART (A0B1C0, BRAAK II, Thal 0, CERAD none), lacunar infarcts (cerebellar cortex, basal ganglia, frontal cortex)		NA																	
	1870	1870		NM-227		Control				Barcelona Brain Bank	+		+				97	F						7.33								1		0	AD (A3B1C2, BRAAK II, Thal 5, CERAD moderate, mild CAA), AGD II, multiple infarcts (cortical and subcortical)		NA																	
	1888	1888		NM-228		Control				Barcelona Brain Bank	+		+				93	F						5.5								1		0	AGD III, low AD (A3B1C2, BRAAK II, Thal 4, CERAD B, moderate CAA), infarct thalamus		NA																	
	1937	1937		NM-229		Control				Barcelona Brain Bank	+		+				83	F						7.55								1		0	AD (A3B1C2, BRAAK II, Thal 5, CERAD B,  CAA capillar), ARTAG (temporomedial TSA)		NA																	
	1949	1949		NM-230		Control				Barcelona Brain Bank	+		+				86	M						7.42								1		0	AD (A2B1C1, BRAAK II, Thal 3, CERAD B), ARTAG (frontobasal and temporomedial TSA), AGD II, LBD (Braak 1, brainstem), acute microinfarct (frontal, motor cortex, caudate, putamen)		NA																	
	1717	1717		NM-231		CBS with parkinsonism				Barcelona Brain Bank	+		+				77	M						7								1		0	PSP, possible PART (A1B0C0, BRAAK 0, Thal 1, CERAD none)		NA																	
	1662	1662		NM-232		CBS vs PSP vs FTLD				Barcelona Brain Bank	+		+				83	F						7.75								1		0	PSP, AD (A2B1C2, BRAAK I, Thal 3, CERAD moderate), microinfarct right amygdala		NA																	
	1713	1713		NM-233		CBS				Barcelona Brain Bank	+		+				77	M						11								1		0	PSP, AGD I, AD (A3B3C2, BRAAK V, Thal 5, CERAD moderate, sparse CAA), LBD (Braak 4, limbic)		NA																	
	1958	1958		NM-234		CBS				Barcelona Brain Bank	+		+				71	F						5.42								1		0	PSP, AD (A2B1C2, BRAAK II, Thal 3, CERAD moderate, moderate CAA), low changes ateriosclerosis and arteriolohialinosis		NA																	
	1959	1959		NM-235		CBS				Barcelona Brain Bank	+		+				81	M						5.33								1		0	PSP, AD (A3B3C2, BRAAK V, Thal 5, CERAD moderate), HS (TDP-42, limbic), SVD		NA																	
	1058	1058		NM-236		CBD with dystonia				Barcelona Brain Bank	+		+				69	F						12.17								1		0	CBD, TDP43		NA																	
	1772	1772		NM-237		CBD vs PSP vs FTLD				Barcelona Brain Bank	+		+				72	M						16								1		0	PSP, possible PART (A1B1C0, BRAAK 1, Thal 2, CERAD none)		NA																	
	1798	1798		NM-238		CBD vs PSP				Barcelona Brain Bank	+		+				78	F						5.5								1		0	CBD, AGD II, AD (A3B1C2, BRAAK II, Thal 4, CERAD moderate)		NA																	
	1927	1927		NM-239		CBD (atypical)				Barcelona Brain Bank	+		+				64	M						5								1		0	CBD, isolated TDP43 (substantia nigra)		NA																	
	1549	1549		NM-240		CBD				Barcelona Brain Bank	+		+				84	F						7.67								1		0	PSP, AD (A3B2C1, BRAAK III, Thal 5, CERAD sparse, sparse CAA)		NA																	
	663	663		NM-241		CBD				Barcelona Brain Bank	+		+				74	F						4								1		0	CBD		NA																	
	1092	1092		NM-242		CBD				Barcelona Brain Bank	+		+				62	F						15.25								1		0	mixed tauopathy (PSP, CBD, PSP mainly)		NA																	
	1204	1204		NM-243		CBD				Barcelona Brain Bank	+		+				74	M						14.5								1		0	CBD, AD (A2B0C1, BRAAK 0, Thal 3, CERAD sparse, sparse CAA)		NA																	
	1518	1518		NM-244		CBD				Barcelona Brain Bank	+		+				66	M						5								1		0	CBD with PSP-like distribution, AGD		NA																	
	1810	1810		NM-245		CBD				Barcelona Brain Bank	+		+				74	F						8.25								1		0	CBD, definite PART (A0B1C0, BRAAK II, Thal 0, CERAD none)		NA																	
	1754	1754		NM-246		atypical parkinsonism				Barcelona Brain Bank	+		+				75	F						13.5								1		0	PSP, AGD II		NA																	
	1603	1603		NM-247		Atypical AD				Barcelona Brain Bank	+		+				76	M						5.58								1		0	PSP		NA																	
	995	995		NM-248		AD, genetic			MAPT (P301L)	Barcelona Brain Bank	+		+				75	M						5.92								1		0	CBD		NA																	
	1108	1108		NM-249		AD vs CBD				Barcelona Brain Bank	+		+				87	F						14.75								1		0	PD (LBD, Braak 5, McKeith limbic), AGD III		NA																	
	443	443		NM-250		AD (progressive aphasia)				Barcelona Brain Bank	+		+				76	F						6.75								1		0	CBD, LBD (Braak 4, limbic)		NA																	
	1384	1384		NM-251		AD				Barcelona Brain Bank	+		+				87	F						18.5								1		0	PSP, AD (A3B2C2, BRAAK III, Thal 5, CERAD moderate, moderate CAA)		NA																	
	1562	1562		NM-252		AD				Barcelona Brain Bank	+		+				92	F						16								1		0	PSP, AD (A3B2C3, BRAAK III, Thal 5, CERAD frequent, severe CAA), HS (TDP-43)		NA																	
	1239	1239		NM-253		AD				Barcelona Brain Bank	+		+				91	M						5								1		0	MSA, PD (Braak 4, limbic), AD (A2B3C2, BRAAK III, Thal 3, CERAD moderate, severe CAA)		NA																	
	1034	1034		NM-254		AD			MAPT (exons 1 and 9-13)	Barcelona Brain Bank	+		+				74	F						3.33								1		0	CBD		NA																	
	1235	1235		NM-255		AD				Barcelona Brain Bank	+		+				77	F						18.5								1		0	CBD, FTLD-MND-TDP43, HS, capillar telangiectasia (pons, subcortical white matter of right temporal cortex)		NA																	
	1291	1291		NM-256		AD				Barcelona Brain Bank	+		+				79	F						10.5								1		0	CBD, AGD I, AD (A3B2C2, BRAAK IV, Thal 4, CERAD moderate, sparse CAA), vascular encephalopathy with multiple lacunar infarcts (basal ganglia)		NA																	
	1356	1356		NM-257		AD				Barcelona Brain Bank	+		+				72	M						7								1		0	CBD, multiple infarcts (cortex, striatum, pons)		NA																	
	O14/52	O14/052	A11	NM-258		PD	PD			Park West			+	+		whole brain	71	F						72								0		1				+	-					+										
	O14/53	O14/053	A13	NM-259		PD	PD			Park West			+	+		whole brain	91	M						36								0		1				+	-					+										
	O12/08	O12/008	B085	NM-260		PD	PD			Park West			+	+		whole brain	76	M						72								0		1				+	acc respiratory failure (basilar inf??)					+										
	O11/310	O11/310	F18	NM-261		PD	PD			Park West			+	+		whole brain	81	F						30								0		1				+	respiratory failure, pneumonia					+										
	O16/239	O16/239	B037	NM-262		PD	PD			Park West			+	+		whole brain	80	F						72			1365					0		1				+						+										
	O14/109	O14/109	B074	NM-263		PD	PD			Park West			+	+		whole brain	87	F						96								0		1				+						+										
	O16/82	O16/082	A19	NM-264		PD	PD			Park West			+	+		whole brain	70	M						< 24								0		1				+	-					+										
	O16/190	O16/190	A10	NM-265		PD	PD			Park West			+	+		whole brain	86	M						< 24 								0		1				+	FCF, kidney failure					+										
	O17/114	O17/114	B53	NM-266		PD				Park West			+	+		whole brain	70	M						90			1562					0		1					PD (malnutrition?)															
	O18/160	O18/160	B28	NM-267		PD				Park West			+	+		whole brain	77	M						< 24			1327					1	8	1																				
	O17/257	O17/257		NM-268		PD	PD			Neuromics Tissue Bank			+	+		whole brain		F				36										0		1																				
	O19/26	O19/026		NM-269		PD				Park West			+	+		whole brain		F														0		1																				
	O19/139	O19/139		NM-270		PD				Park West			+	+		whole brain		F														1		1																				
	O18/212	O18/212		NM-271		Control				Neuromics Tissue Bank			+	+		whole brain	87	F														1	8	1																				
	O19/43	O19/43		NM-272		Control				Neuromics Tissue Bank			+	+		whole brain	95	F														1	8	1																				
	O19/123	O19/123		NM-273		PD				Park West			+	+		whole brain	82	F																																				
	O19/188	O19/188		NM-274		Control		calcified falx meningeoma, possible pituitary microadenoma		Neuromics Tissue Bank			+	+		whole brain	95	F						30															Likely pyelonephritis, urosepsis	Atrial fibrillation, hypertension, cataract, agerelated macula degeneration	Carvedilol 25mgx1, Eliquis 2,5mgx1, Triatec 2,5mgx2, Esidrex 12,5mg x1		brain (frozen+formalin), heart, kidney, adrenal gland, colon, skeletal muscle, liver											
	O19/194	O19/194		NM-275		PD				Park West			+	+		whole brain	83	M						37																														
	PD004	PD004		NM-276		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1), substantia nigra (A1D1)											
	PD009	PD009		NM-277		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2)											
	PD010	PD010		NM-278		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C2), substantia nigra (BSB8)											
	PD013	PD013		NM-279		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3), substantia nigra (BSB2)											
	PD016	PD016		NM-280		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3)											
	PD017	PD017		NM-281		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1)											
	PD020	PD020		NM-282		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD021	PD021		NM-283		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3)											
	PD023	PD023		NM-284		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3)											
	PD028	PD028		NM-285		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C3)											
	PD029	PD029		NM-286		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C4)											
	PD032	PD032		NM-287		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4C3)											
	PD034	PD034		NM-288		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD039	PD039		NM-289		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C7)											
	PD041	PD041		NM-290		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A3)											
	PD045	PD045		NM-291		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD047	PD047		NM-292		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2)											
	PD050	PD050		NM-293		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD051	PD051		NM-294		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B4)											
	PD055	PD055		NM-295		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C3)											
	PD060	PD060		NM-296		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1)											
	PD061	PD061		NM-297		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C6)											
	PD067	PD067		NM-298		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1)											
	PD074	PD074		NM-299		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3D3)											
	PD077	PD077		NM-300		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD079	PD079		NM-301		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C3)											
	PD081	PD081		NM-302		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4C1)											
	PD082	PD082		NM-303		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD084	PD084		NM-304		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3)											
	PD089	PD089		NM-305		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3D8)											
	PD090	PD090		NM-306		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD093	PD093		NM-307		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B3), substantia nigra (BSA3)											
	PD099	PD099		NM-308		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1)											
	PD102	PD102		NM-309		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C3)											
	PD104	PD104		NM-310		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3D4), substantia nigra (BSA3)											
	PD106	PD106		NM-311		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3), substantia nigra (BSA2)											
	PD113	PD113		NM-312		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C3)											
	PD114	PD114		NM-313		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B3)											
	PD115	PD115		NM-314		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3), substantia nigra (BSA3)											
	PD117	PD117		NM-315		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A1)											
	PD120	PD120		NM-316		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD121	PD121		NM-317		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4D7)											
	PD122	PD122		NM-318		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A3), substantia nigra (BSA2)											
	PD124	PD124		NM-319		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (BSB2)											
	PD125	PD125		NM-320		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B2)											
	PD131	PD131		NM-321		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B1), substantia nigra (BSA3)											
	PD132	PD132		NM-322		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (BSA2)											
	PD134	PD134		NM-323		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B3), substantia nigra (BSA1)											
	PD142	PD142		NM-324		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3)											
	PD143	PD143		NM-325		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3)											
	PD153	PD153		NM-326		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2)											
	PD154	PD154		NM-327		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B1), substantia nigra (BSB4)											
	PD160	PD160		NM-328		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD163	PD163		NM-329		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A3)											
	PD171	PD171		NM-330		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2D1)											
	PD172	PD172		NM-331		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD175	PD175		NM-332		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2)											
	PD180	PD180		NM-333		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (P2C3)											
	PD182	PD182		NM-334		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C4), substantia nigra (BSA2)											
	PD183	PD183		NM-335		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4C3)											
	PD184	PD184		NM-336		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD187	PD187		NM-337		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (SNC8)											
	PD188	PD188		NM-338		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD194	PD194		NM-339		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD197	PD197		NM-340		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD201	PD201		NM-341		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD203	PD203		NM-342		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (P1C1)											
	PD207	PD207		NM-343		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B3), substantia nigra (BSA2)											
	PD208	PD208		NM-344		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2)											
	PD216	PD216		NM-345		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B1)											
	PD226	PD226		NM-346		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2D1), substantia nigra (BSB3)											
	PD229	PD229		NM-347		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C4), substantia nigra (BSA1)											
	PD231	PD231		NM-348		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A3)											
	PD233	PD233		NM-349		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B1)											
	PD239	PD239		NM-350		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD247	PD247		NM-351		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3), substantia nigra (BS1)											
	PD252	PD252		NM-352		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2)											
	PD258	PD258		NM-353		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A5), substantia nigra (NIGRA)											
	PD261	PD261		NM-354		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA1)											
	PD268	PD268		NM-355		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A5B3)											
	PD269	PD269		NM-356		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2), substantia nigra (BSE1)											
	PD275	PD275		NM-357		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4B6)											
	PD283	PD283		NM-358		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD286	PD286		NM-359		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1), substantia nigra (NIGRA)											
	PD289	PD289		NM-360		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1)											
	PD294	PD294		NM-361		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4D1)											
	PD295	PD295		NM-362		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4B2)											
	PD305	PD305		NM-363		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A1)											
	PD306	PD306		NM-364		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD309	PD309		NM-365		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3), substantia nigra (P1D3)											
	PD311	PD311		NM-366		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A5), substantia nigra (RSN)											
	PD317	PD317		NM-367		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4B1)											
	PD411	PD411		NM-368		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD413	PD413		NM-369		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3D3), substantia nigra (BSB2)											
	PD427	PD427		NM-370		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2)											
	PD458	PD458		NM-371		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A6), substantia nigra (P1E3)											
	PD460	PD460		NM-372		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C1), substantia nigra (BSA1)											
	PD466	PD466		NM-373		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (BSA3)											
	PD479	PD479		NM-374		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B1), substantia nigra (BSA3)											
	PD493	PD493		NM-375		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B5)											
	PD495	PD495		NM-376		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD501	PD501		NM-377		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2), substantia nigra (BSB1)											
	PD502	PD502		NM-378		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C3)											
	PD507	PD507		NM-379		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3C8)											
	PD537	PD537		NM-380		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C4), substantia nigra (BSA5)											
	PD538	PD538		NM-381		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD541	PD541		NM-382		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD542	PD542		NM-383		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD544	PD544		NM-384		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1)											
	PD546	PD546		NM-385		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD554	PD554		NM-386		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B4), substantia nigra (BSC2)											
	PD566	PD566		NM-387		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B1), substantia nigra (BSC2)											
	PD650	PD650		NM-388		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2D6)											
	PD655	PD655		NM-389		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (BSA2)											
	PD659	PD659		NM-390		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (BSA8)											
	PD666	PD666		NM-391		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C7), substantia nigra (P1D1)											
	PD668	PD668		NM-392		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C6)											
	PD679	PD679		NM-393		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2)											
	PD680	PD680		NM-394		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C6)											
	PD681	PD681		NM-395		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2D6), substantia nigra (BS2)											
	PD690	PD690		NM-396		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3), substantia nigra (BSA2)											
	PD701	PD701		NM-397		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B4)											
	PD706	PD706		NM-398		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2)											
	PD714	PD714		NM-399		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C6)											
	PD718	PD718		NM-400		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD721	PD721		NM-401		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2)											
	PD722	PD722		NM-402		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD723	PD723		NM-403		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C8)											
	PD724	PD724		NM-404		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B7), substantia nigra (BSA7)											
	PD726	PD726		NM-405		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2E1), substantia nigra (BSA1)											
	PD728	PD728		NM-406		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B8)											
	PD731	PD731		NM-407		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2)											
	PD732	PD732		NM-408		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	PD733	PD733		NM-409		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (BSA8)											
	PD736	PD736		NM-410		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2)											
	PD740	PD740		NM-411		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A5), substantia nigra (P1B1)											
	PD744	PD744		NM-412		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B10)											
	PD745	PD745		NM-413		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD747	PD747		NM-414		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD748	PD748		NM-415		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C7)											
	PD755	PD755		NM-416		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B7), substantia nigra (BSA5)											
	PD758	PD758		NM-417		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B9)											
	PD759	PD759		NM-418		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A1)											
	PD760	PD760		NM-419		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD761	PD761		NM-420		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2)											
	PD763	PD763		NM-421		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8), substantia nigra (BSA8)											
	PD765	PD765		NM-422		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8), substantia nigra (BSA6)											
	PD766	PD766		NM-423		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA6)											
	PD780	PD780		NM-424		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A3)											
	PD781	PD781		NM-425		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD785	PD785		NM-426		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4B7)											
	PD789	PD789		NM-427		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD808	PD808		NM-428		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A3)											
	PD809	PD809		NM-429		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A1)											
	PD816	PD816		NM-430		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA1)											
	PD818	PD818		NM-431		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8)											
	PD826	PD826		NM-432		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8)											
	PD831	PD831		NM-433		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A5), substantia nigra (BSA8)											
	PD832	PD832		NM-434		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A9)											
	PD887	PD887		NM-435		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD893	PD893		NM-436		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD895	PD895		NM-437		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD896	PD896		NM-438		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0900	PD0900		NM-439		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8)											
	PD0901	PD0901		NM-440		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0902	PD0902		NM-441		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A9)											
	PD0903	PD0903		NM-442		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0904	PD0904		NM-443		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0906	PD0906		NM-444		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A1)											
	PD0908	PD0908		NM-445		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0910	PD0910		NM-446		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0913	PD0913		NM-447		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3)											
	PD0914	PD0914		NM-448		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0915	PD0915		NM-449		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8)											
	PD0917	PD0917		NM-450		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0924	PD0924		NM-451		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A9)											
	PD0927	PD0927		NM-452		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8)											
	PD0931	PD0931		NM-453		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2)											
	PD0934	PD0934		NM-454		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4E7)											
	PD0935	PD0935		NM-455		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0936	PD0936		NM-456		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0938	PD0938		NM-457		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A8)											
	PD0940	PD0940		NM-458		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0942	PD0942		NM-459		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A5)											
	PD0944	PD0944		NM-460		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A8)											
	PD0946	PD0946		NM-461		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0948	PD0948		NM-462		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A9)											
	PD0949	PD0949		NM-463		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A10)											
	PD0950	PD0950		NM-464		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0955	PD0955		NM-465		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0957	PD0957		NM-466		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0959	PD0959		NM-467		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A5)											
	PD0960	PD0960		NM-468		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0966	PD0966		NM-469		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD0967	PD0967		NM-470		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A10)											
	PD0968	PD0968		NM-471		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0979	PD0979		NM-472		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7)											
	PD0984	PD0984		NM-473		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD1002	PD1002		NM-474		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6)											
	PD1004	PD1004		NM-475		PD				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1)											
	C036	C036		NM-476		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B1), substantia nigra (BSA2)											
	C043	C043		NM-477		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A5), substantia nigra (P2D5)											
	C046	C046		NM-478		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B2), substantia nigra (P2E6)											
	C049	C049		NM-479		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A5), substantia nigra (P2D3)											
	C054	C054		NM-480		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A3), substantia nigra (BSB2)											
	C064	C064		NM-481		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4B5), substantia nigra (P1C3)											
	C065	C065		NM-482		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A2), substantia nigra (BSA2)											
	C072	C072		NM-483		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA1)											
	C073	C073		NM-484		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA2)											
	C074	C074		NM-485		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A5), substantia nigra (P2D8)											
	C076	C076		NM-486		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C1), substantia nigra (BSA3)											
	C077	C077		NM-487		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A4), substantia nigra (P1D1)											
	C083	C083		NM-488		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A9), substantia nigra (BSA7)											
	C084	C084		NM-489		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A9), substantia nigra (BSA8)											
	C085	C085		NM-490		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA3)											
	C087	C087		NM-491		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A9), substantia nigra (BSA9)											
	C088	C088		NM-492		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA7)											
	C089	C089		NM-493		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A10), substantia nigra (BSA1)											
	C090	C090		NM-494		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSB1)											
	PDC027	PDC027		NM-495		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B3), substantia nigra (BSA1)											
	PDC030	PDC030		NM-496		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B3), substantia nigra (A1C1)											
	PDC059	PDC059		NM-497		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A2), substantia nigra (BSA1)											
	PDC068	PDC068		NM-498		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C5), substantia nigra (BSA1)											
	PDC078	PDC078		NM-499		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A8), substantia nigra (BSA2)											
	PDC081	PDC081		NM-500		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA8)											
	PDC084	PDC084		NM-501		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A3), substantia nigra (BSC2)											
	PDC085	PDC085		NM-502		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A2C7), substantia nigra (BSA6)											
	PDC086	PDC086		NM-503		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA7)											
	PDC087	PDC087		NM-504		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A2B8), substantia nigra (A1C5)											
	PDC088	PDC088		NM-505		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B3), substantia nigra (BSA3)											
	PDC091	PDC091		NM-506		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA8)											
	PDC092	PDC092		NM-507		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3B1), substantia nigra (BSA1)											
	PDC093	PDC093		NM-508		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A5A9), substantia nigra (BSA8)											
	PDC105	PDC105		NM-509		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA2)											
	PDC107	PDC107		NM-510		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA8)											
	PDC110	PDC110		NM-511		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA7)											
	PDC111	PDC111		NM-512		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA1)											
	PDC112	PDC112		NM-513		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA6)											
	PDC114	PDC114		NM-514		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BSA7)											
	PDC116	PDC116		NM-515		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A7), substantia nigra (BSA9)											
	PDC121	PDC121		NM-516		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A9), substantia nigra (BSA4)											
	PDC123	PDC123		NM-517		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A3), substantia nigra (BS7)											
	PDC125	PDC125		NM-518		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A3A9), substantia nigra (BS2)											
	PDC126	PDC126		NM-519		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BS7)											
	PDC131	PDC131		NM-520		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4A6), substantia nigra (BS8)											
	PDC134	PDC134		NM-521		Control				MS-PD Brain Bank																						1		0									prefrontal cortex (A4B5), substantia nigra (BSC1)											
	BBN_4193	A012/12, 		NM-522		Control		"Adenocarcinoma of the right lung
S.L.E."		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			51	F	White (European)					61		6.21						1		0	No abnormality detected (Present) [+NAD], 	normal brain			metastatic adenocarcinoma				BA9, Nigra											
	BBN_4589	A081/12, 		NM-523		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			69	M	unknown					58								1		0	"Progressive supranuclear palsy with FTLD (Present) [+Ndgen.FTLD.NonADTau.PSP], 
Tauopathy, non-Alzheimer's (Present) [+Ndgen.NonADTau], "	Tauopathy strongly favouring Progressive Supranuclear Palsy			Septicaemia; urinary tract infection				BA9, Nigra											
	BBN_9683	A245/00, 		NM-524		CBD		CBD - Pick's disease spectrum		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			68	M	unknown					18								1		0	AD not otherwise specified (Present) [+Ndgen.AD.ADNOS], 	ALZHEIMER'S DISEASE: DEFINITE			BRONCHOPNEUMONIA				BA9, Nigra											
	BBN_9820	A187/06, 		NM-525		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			71	F	unknown					48		6.42						1		0	Other pathology (Present) [+Other], 	Alzheimer changes (NIA/Reagan) Braak I							BA9, Nigra											
	BBN_9870	A254/07, 		NM-526		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			75	M	unknown					17				Braak tangle stage V 				1		0	Braak tangle stage V (Present) [+Ndgen.BandBV], 	Alzheimer's pathology Braak V with Parkinsonian features			CVA				BA9, Nigra											
	BBN_9892	A264/08, 		NM-527		PD		Dementia with Lewy bodies		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			79	M	unknown					39				Braak tangle stage V 				1		0	Braak tangle stage V (Present) [+Ndgen.BandBV], 	Alzheimer's disease (modified Braak V) with amyloid angiopathy; Dementia with Lewy bodies (diffuse neocortical type)							BA9, Nigra											
	BBN_10275	A035/06, 		NM-528		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			65	M	unknown					16		6.28						1		0	Progressive supranuclear palsy with FTLD (Present) [+Ndgen.FTLD.NonADTau.PSP], 	Progressive Supranuclear Palsy			bronchopneumonia				BA9, Nigra											
	BBN_10283	A276/05, 		NM-529		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			92	M	unknown					11				Braak tangle stage III 				1		0	Braak tangle stage III (Present) [+Ndgen.BandBIII], 	Mild alzheimer's type changes due to ageing Braak III							BA9, Nigra											
	BBN_10295	A218/05, 		NM-530		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			73	M	unknown					52		6.4						1		0	Progressive supranuclear palsy with FTLD (Present) [+Ndgen.FTLD.NonADTau.PSP], 	Progressive Supranuclear Palsy			Pneumonia				BA9, Nigra											
	BBN_10310	A075/05, 		NM-531		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			55	M	unknown					48		6.23						1		0	Progressive supranuclear palsy with FTLD (Present) [+Ndgen.FTLD.NonADTau.PSP], 	Progressive Supranuclear Palsy			MND				BA9, Nigra											
	BBN_10611	A019/12, 		NM-532		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			92	F	unknown					30		6.36	1212	Braak tangle stage III 				1		0	Braak tangle stage III (Present) [+Ndgen.BandBIII], 	Control; consistent with ageing (tau Braak stage 3)	"APOE=3/3
"					"

   "	BA9, Nigra											
	BBN_11072	A405/12		NM-533		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			91	M	unknown					51		6.98	1464	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 2 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 2 (Present) [+Ndgen.Thal2], "	Consistent with ageing, Braak stage 2; Possible control	"APOE=3/3
"						BA9, Nigra											
	BBN_14408	A002/13		NM-534		Control		Control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			90	M	unknown					70		6.9	1252	Braak tangle stage 0 	CERAD no plaques 		Thal phase 0 	1		0	"No abnormality detected (Present) [+NAD], 
Braak tangle stage 0 (Present) [+Ndgen.BandB0], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	Mild age-related changes (control brain) - AD modified Braak stage + with mild focal amyloid angiopathy			Myocardial Infarction				BA9, Nigra											
	BBN_15602	A241/11, 		NM-535		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			82	M	unknown					33		6.28				Limbic Lewy body disease, 		1		0	Limbic Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBLim], 	Lewy body pathology - Limbic stage (BNE & McKeith) Braak 5; Very mild Alzheimer-type changes BNE stage 1			bronchopneumonia				BA9, Nigra											
	BBN_15800	A075/01, 		NM-536		PD	MSA			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				61	F	unknown					48								1		0	Multiple system atrophy (Present) [+Ndgen.Mov.Synuc.MSA], 								BA9											
	BBN_16196	A152/13		NM-537		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			78	F	unknown					70		6.44	1241	Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	small vessel cerebrovascular disease; focal amyloid angiopathy; Tau pathology amounting to AD modified Braak (BNE) stage 2 with limbic TDP-43 positivity - most likely related to ageing	"APOE=3/3
"						BA9, Nigra											
	BBN_16206	A214/11, 		NM-538		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			71	M	unknown					47		6.64						1		0	Progressive supranuclear palsy with FTLD (Present) [+Ndgen.FTLD.NonADTau.PSP], 	Progessive Supranuclear Palsy (PSP)							BA9, Nigra											
	BBN_16236	A136/10, 		NM-539		Control	Control			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			89	F	unknown					65		6.43						1		0	No abnormality detected (Present) [+NAD] , 	Control case but with Hypoxic-type changes and amyloid angiopathy (AD BNE modified Braak score I-II)			aortic sclerosis; infection				BA9, Nigra											
	BBN_17087	A101/89, 		NM-540		Control	Control			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			82	M	unknown					48		6.54						1		0	No abnormality detected (Present) [+NAD] , 	NORMAL ADULT BRAIN	"APOE=3/4
PSEN1=1/1
"		Bronchopneumonia				BA9, Nigra											
	BBN_17088	A100/89, 		NM-541		Control	Control			KCL- London Neurodegenerative Diseases Brain Bank	+	-		+			64	M	unknown					48		6.71						1		0	No abnormality detected (Present) [+NAD] , 	NORMAL ADULT BRAIN	"APOE=2/3
PSEN1=1/2
"		ACUTE PULMONARY OEDEMA				Nigra											
	BBN_17090	A098/89, 		NM-542		Control	Control			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			85	M	unknown					48		6.33						1		0	No abnormality detected (Present) [+NAD] , 	NORMAL ADULT BRAIN	"APOE=3/3
PSEN1=2/2
"		Ischaemic heart disease				BA9, Nigra											
	BBN_17091	A097/89, 		NM-543		Control	Control			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				83	F	unknown					48		7.03						1		0	No abnormality detected (Present) [+NAD] , 	NORMAL ADULT BRAIN	"APOE=3/3
PSEN1=1/2
"		Pulmonary embolism				BA9											
	BBN_17092	A096/89, 		NM-544		Control	Control			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				68	F	unknown					42		6.77						1		0	No abnormality detected (Present) [+NAD] , 	NORMAL ADULT BRAIN	"APOE=2/2
PSEN1=1/2
"		Ischaemic heart disease				BA9											
	BBN_17094	A089/89, 		NM-545		Control	Control			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				75	M	unknown					44		6.32						1		0	No abnormality detected (Present) [+NAD] , 	NORMAL ADULT BRAIN	"APOE=3/3
PSEN1=1/2
"		CARCINOMA OF THE LEFT KIDNEY				BA9											
	BBN_18409	A209/13, 		NM-546		Control		"Cardiac problems,
Prostate cancer"		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			79	M	White (European)					55		6.84	1381	Braak tangle stage II 				1		0	"No abnormality detected (Present) [+NAD], 
Braak tangle stage II (Present) [+Ndgen.BandBII], "	Early tauopathy, BNE stage 2-3 (likely ageing changes - possible control); mild to moderate small vessel disease							BA9, Nigra											
	BBN_18812	A212/13		NM-547		Control		small cell bladder/prostate tumour 		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			58	M	White (European)					47		6.94						1		0	No abnormality detected (Present) [+NAD], 	Minimal ageing changes - control	"APOE=2/2
"		disseminated cancer of bladder 			chemotherapy and radiotherapy	BA9, Nigra											
	BBN_20001	A398/13, 		NM-548		Control		Prostate cancer		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			91	M	Indian					38		6.17		Braak tangle stage IV 				1		0	Braak tangle stage IV (Present) [+Ndgen.BandBIV], 	Alzheimer type changes, consistent with BNE stage 4; Prominent white matter atrophy with corpora amylacea deposition, mild small vessel disease			Metastatic prostate cancer				BA9, Nigra											
	BBN_20012	A368/13		NM-549		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			87	F	White (European)					45		6.16		Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Capillary CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.CapCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	Alzheimer type changes (ageing), BNE stage 2, control; mild small vessel disease, mild amyloid angiopathy	"APOE=3/3
"					"Anti-hypertensive
BDR data indicates:
Drugs:{
Amiodarone, Amlodipine, Aspirin, Asprin, Bendroflumethiazide, Betahistamine, Betahistine, Lansoprazole, Moxonidine, Ramipril, Simvastatin
}
Indications:{
Anti-arrhythmia, Blood pressure, Blood thinner, Blood Thinning, Cholesterol, Diuretic, Ears, High blood pressure, Menieres, Reflux, Stomach Acid}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN_20040	A407/13, 		NM-550		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			80	F	White (European)					22		5.73						1		0	No abnormality detected (Present) [+NAD], 	Consistent with ageing (Tau Braak stage 2) control			Lung cancer				BA9, Nigra											
	BBN_20997	A036/14, 		NM-551		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			72	F	White (European)					35		6.08						1		0	Progressive supranuclear palsy with FTLD (Present) [+Ndgen.FTLD.NonADTau.PSP], 	Progressive Supranuclear Palsy; very early Alzheimer type changes						"diazepam 2.5mg in 5ml
paracetamol 250mg in 5ml
morphine sulphate
midazolam 10mg in 2ml injection
ondansetron 4mg in 5ml
cyclizine 50mg in 1ml injection

simvastatin 20mg
lossartan/hydrochlorothiazide
metformin 500mg tds
"	BA9, Nigra											
	BBN_21005	A051/14		NM-552		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			76	F	unknown					22		6.01		Braak tangle stage II 				1		0	Braak tangle stage II (Present) [+Ndgen.BandBII], 	Tau Braak stage 2 consistent with ageing, control	"APOE=3/3
"					"omeprazole
oxycodone hydrochloride
metoclopramide hydrochloride
enoxaparin
midazolam
nystatin
glycopyrronium bromide
diamorphine hydrochloride



   "	BA9, Nigra											
	BBN_21793	A073/14		NM-553		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			72	F	White (European)					47		6.9	1313	Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	control brain (modified braak (BNE) AD stage 1 and 2)	"APOE=3/3
"		metastasised cancer 			"domperidone 10mg
nystan 
trimethoprim 200mg
colecalciferol 
"	BA9, Nigra											
	BBN_21801	A082/14, 		NM-554		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			68	M	White (European)					60		5.54						1		0	No abnormality detected (Present) [+NAD], 	Tau Braak stage II; no evidence of neurodegeneration possible control			heart attack				BA9, Nigra											
	BBN_21803	A134/14, 		NM-555		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			92	F	White (European)					29			1238	Braak tangle stage III 				1		0	"Cerebrovascular arteriolosclerosis and/or lipohyalinosis (non-amyloid SVD) (Present) [+CVD.Vasc.Arterioscl], 
Braak tangle stage III (Present) [+Ndgen.BandBIII], 
TDP43 pathology accompanying AD/ other disease/ ageing (Present) [+Ndgen.TDP.TDPaccomp], "	Alzheimer's disease type changes BNE stage 3, possible control; mild small vessel disease TDP-43 mild in hippocampus							BA9, Nigra											
	BBN_22594	A105/14, 		NM-556		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			76	F	unknown					20		6.57						1		0	No abnormality detected (Present) [+NAD], 	Control brain						"CONOTRANE CREAM 
GLYCEROL 4MG
BISACODYL 10MG
PREDNISOLONE 5MG
CO-AMOXICLAV 250MG/125MG TABLETS
MEPTAZINOL 200MG
FLUDROCORTISONE 100MG
AMITRIPTYLINE 1OMG
SIMVASTATIN 40MG
PHENOXYMETHYLPENICILLIN 250MG
"	BA9, Nigra											
	BBN_22617	A132/14, 		NM-557		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			66	F	White (European)					50		6.53	1212	Braak tangle stage II 				1		0	Braak tangle stage II (Present) [+Ndgen.BandBII], 	Control brain; Alzheimer's disease BNE stage II						"midazolam 2.5-5mg
glycopyrronium 200mcg/mL
levomepromazine 25mg/mL
alfentanil 1mg/2mL
lansoprazole 30mg
amlodipine 10mg
loperamide 2mg
fentanyl transdermal 37mg
cyclizine 50mg
oxycodone 7.5-1omg
paracetamol 1000mg
"	BA9, Nigra											
	BBN_22991	A158/14, 		NM-558		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				73	F	unknown					27		6.4	1095	Braak tangle stage I 				1		0	Braak tangle stage I (Present) [+Ndgen.BandBI], 	Early ageing changes BNE stage 1, control						"thiamine 100mg
cyclizine 50mg
omeprazole 20mg
cetirizine 10mg
"	BA9											
	BBN_23398	A174/14		NM-559		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			83	M	White (European)					31		5.95	1184	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Moderate arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.ModCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	Tau Braak Stage 2 consistent with ageing process, control	"APOE=3/3
"		"1a. bronchopneumonia
1b. Melanonma with liver, Lung and Bone mets."			"

   "	BA9, Nigra											
	BBN_24200	A177/14, 		NM-560		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			67	F	White (European)					62		6.84		Braak tangle stage II 				1		0	Braak tangle stage II (Present) [+Ndgen.BandBII], 	Control brain- very mild Alzheimer's disease BNE stage 2			"lung infection
heart attack"			"fortisip compact protein liquid
hypromellose 0.32% 
colgate duraphat
amoxicillin 250mg"	BA9, Nigra											
	BBN_24243	A250/14		NM-561		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			69	F	White (European)					48		5.96		Braak tangle stage 0 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Braak tangle stage 0 (Present) [+Ndgen.BandB0], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	Control brain	"APOE=3/4
"		1a: advanced pancreatic cancer			"oxycontin 10mg
cyclizine 50mg
buscupan
movicol


   "	BA9, Nigra											
	BBN_24246	A246/14		NM-562		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			97	F	White (European)					39		5.98		Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	Very mild Alzheimer's disease type changes BNE stage 2, control; Argyrophilic Grains in the limbic system	"APOE=3/3
"		"1a. Acute distal aortic occlusion 2. chronic kidney disease and heart failure
2. chronic kidney disease and heart failure"			"doxazosin 4mg
isosorbide mononitrate 20mg
latanoprost 50mg
atenolol 50mg
furosemide 40mg
beclometasone 200mg inhaler
salbutamol 100mg evohaler
digoxin


   "	BA9, Nigra											
	BBN_24370	A282/14,		NM-563		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			68	F	White (European)					53		6.81		Braak tangle stage III 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Braak tangle stage III (Present) [+Ndgen.BandBIII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	Tau braak stage III consistent with ageing, possible control	"APOE=3/3
"		1a. Metastatic carcinoma of breast			"ramipril 2.5mg

BDR data indicates:
Drugs:{
denosumab, Dexamethasone, Omeprazole, Ramipril
}
Indications:{
Blood pressure, Bones, breathing, for use with dexamethasone}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN_24371	A319/14, 		NM-564		Control	Control (Braak tau II)			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			90	F	White (European)					44		5.79		Braak tangle stage II 				1		0	Braak tangle stage II (Present) [+Ndgen.BandBII], 	Tau Braak stage 2, control; old small infarct in the cerebellum						"oramorph 10mg
paracetamol "	BA9, Nigra											
	BBN_24379	A297/14, 		NM-565		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			105	M	White (European)					25		6.05		Braak tangle stage II 				1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
Other pathology (Present) [+Other], "	Small blood vessel disease consistent with history of hypertension and tau braak stage 2 consistent with ageing, control			colon cancer			"lansoprazole 15mg
laxido orange oral powder sachets
ramipril 1.25mg
bendroflumethiazide 2.5mg
"	BA9, Nigra											
	BBN_24578	A402/14, 		NM-566		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			83	M	White (European)					10		6.72		Braak tangle stage III 	CERAD moderate density of neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage III (Present) [+Ndgen.BandBIII], 
CERAD moderate density of neuritic plaques (Present) [+Ndgen.CERAD2], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	"Tau Braak stage 3
left hippocampal sclerosis and old micro-infarct in the left parietal lobe 
possible control?"	"APOE=3/4
"		1a. Congestive heart failure1b. ischemic heart disease 2. CKD			"miconazole 20mg
midazolam 10mg
haliperdol 5mg
morphine sulfate 10mg
bumetanide 1mg
doxazosin 4mg
bisoprolol 2.5mg
lansoprazole 15mg


BDR data indicates:
Drugs:{
Aspirin, Atouratenin, Bisoprosol, Bumetanide, Doxazosin, Lansaprozole, Spironolactone
}
Indications:{
Heart Failure}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN_24618	A385/14, 		NM-567		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			82	M	White (European)					21		6.6		Braak tangle stage I 		Limbic Lewy body disease, 		1		0	"Braak tangle stage I (Present) [+Ndgen.BandBI], 
Progressive supranuclear palsy with FTLD (Present) [+Ndgen.FTLD.NonADTau.PSP], 
Limbic Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBLim], "	Tauopathy favouring Progessive Supranuclear Palsy (PSP) and dementia with Lewy bodies (limbic stage)						"rasagiline 1mg
co-careldopa 25mg
clonazepam 500ml
macrogol
codeine 15mg
"	BA9, Nigra											
	BBN_24666	A007/15, 		NM-568		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			74	F	White (European)					66		6.53		Braak tangle stage II 				1		0	Braak tangle stage II (Present) [+Ndgen.BandBII], 	Braak stage 2 consistent with ageing, control			1a. Hospital acquired pneumonia 1b. Chronic obstructive pulmonary disease 2. bilateral lung disease			"carbocisteine
ventolin
atrovent
fenoterol
clenil 250
"	BA9, Nigra											
	BBN_24713	A044/15, 		NM-569		Control		blindness 		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			92	M	White (European)					40.5		6.41		Braak tangle stage II 				1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Hippocampal sclerosis (Present) [+Eplpsy.Hipposclr], 
Braak tangle stage II (Present) [+Ndgen.BandBII], "	focal area of recent severe ischaemic/infarct, possible control?; hippocampal sclerosis and tau Braak stage II			1a. pneumonia 2. heart failure				BA9, Nigra											
	BBN_25640	A139/15		NM-570		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			95	F	White (European)					41		6.44		Braak tangle stage II 				1		0	Braak tangle stage II (Present) [+Ndgen.BandBII], 	Primary age-related tauopathy, BNE stage II, possible control; mild amyloid angiopathy, Old and subacute ischaemic changes	"APOE=2/4
"					"Nitrazepam 5mg
levothyroxine 75mg
bendroflumethiazide 2.5mg
omeprazole 10mg
ferrous fumerate 210mg
furosemide 20mg


   "	BA9, Nigra											
	BBN_25641	A079/15, 		NM-571		Control		possible head injury, due to boxing and jockey history of injuries) had severe skull fracture		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			72	M	White (European)					38				Braak tangle stage IV 				1		0	Braak tangle stage IV (Present) [+Ndgen.BandBIV], 	Changes consistent with ageing, BNE stage 4; no evidence of chronic traumatic encephalopathy, multiple infarcts suggestive of thromboembolism						salbutamol 100mg	BA9, Nigra											
	BBN_25987	A176/15, 		NM-572		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			98	F	White (European)					24		6.77		Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	; Mild limbic TDP-43 pathology, Joseph stage 2 Primary age related tauopathy BNE stage 2, possible control	"APOE=3/4
"		1a. Gastroenteritis 2. old age/ frailty			"
NKDA Allergy
BDR data indicates:
Drugs:{
Bumetanide, digoxin, lactulose, peridopril, thyroxine, unknown, warfarin
}
Indications:{
atrial fibbrulation, atrial fibrilation, blood pressure, direutic, underactive thyroid}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN_26037	A178/15, 		NM-573		PSP				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			88	F	White (European)					44		6.45						1		0	Progressive supranuclear palsy (Present) [+Ndgen.NonADTau.PSP], 	4 repeat tauopathy strongly favouring Progressive Supranuclear Palsy			cardiac arrest /MI			"ramipril
trazodone
travoprost
lansoprazole
nitrazopam
"	BA9, Nigra											
	BBN002.26065	A199/15, 		NM-574		Control		"TIAS
"		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			73	M	White (European)					67		6.16		Braak tangle stage IV 	CERAD moderate density of neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD moderate density of neuritic plaques (Present) [+Ndgen.CERAD2], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Globular glial tauopathy (Present) [+Ndgen.NonADTau.FTLD.GGT], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	Strongly suggestive of Globular Glial Tauopathy (GGT); Co-existing Alzheimer's type changes, BNE stage III-IV, metastatic small cell carcinoma, deseminated	"APOE=3/4
"		carcinomatosis, bronchial cancer			"glycopyrronium bromide
haloperidol 
metoclopramide
midazolam
oxycodone
gabapentin
fentayl 
paracetamol 
thiamine
irbesartan

BDR data indicates:
Drugs:{
ARBESARTAN, felodipine, Irbesartan
}
Indications:{
BP, hypertension}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.26120	A216/15, 		NM-575		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			86	M	White (European)					10.5				Braak tangle stage III 				1		0	"Mild non-amyloid SVD (Present) [+CVD.Vasc.Arterioscl.Mildarterioscl], 
Braak tangle stage III (Present) [+Ndgen.BandBIII], "	mild degree of small vessel disease and tau Braak stage 3 consistent with ageing							BA9, Nigra											
	BBN002.26151	A242/15, 		NM-576		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			82	M	White (European)					26		6.62		Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	Control (very mild Alzheimer disease pathology- modified Braak BNE stage 2)	"APOE=3/4
"					"
BDR data indicates:
Drugs:{
amitriptyline, Amlodipine, candesartan, Candesarten, Detrusetol, Nexium, omeprazole, Temazepam, terazosin
}
Indications:{
Blood Pressure, Enlarged Prostate, gastro-intensinal, Reflux, Sleep, sleeping tablet, stopping incontinence}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.26311	A234/15,		NM-577		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			80	M	White (European)					33.5		6.38		Braak tangle stage I 				1		0	"Braak tangle stage I (Present) [+Ndgen.BandBI], 
Other pathology (Present) [+Other], "	Tau Braak stage 1 and beta-amyloid deposition consistent with ageing, control	"APOE=3/4
"					"simvastatin 10mg
lansoprazole


   "	BA9, Nigra											
	BBN002.26316	A311/15, 		NM-578		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			95	F	White (European)					52.5		6.2		Braak tangle stage II 				1		0	"Moderate arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.ModCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], "	Control; AD BNE stage II, moderate amyloid angiopathy, mild hypoxic type changes	"APOE=3/4
"					"
Cavilon Barrier Cream
Conjugated oestrogen
Conotrane cream
Macrogol 
Polyvinyl alcohol
Pregabalin
Quinine sulphate
Ramipril
Glucogel
Insulin Lantus SoloSTAR 


   "	BA9, Nigra											
	BBN002.26339	A321/15, 		NM-579		Control		not apparent from medical notes 		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			94	M	White (European)					19.5				Braak tangle stage V  Braak tangle stage VI 				1		0	"Cerebrovascular disease (Present) [+CVD], 
Braak tangle stage V (Present) [+Ndgen.BandBV], 
Braak tangle stage VI (Present) [+Ndgen.BandBVI], "	small blood vessel disease and tau braak stage 6 with predominant tau distribution in the occipital lobe							BA9, Nigra											
	BBN002.28118	A375/15, 		NM-580		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			95	M	White (European)					46		6.51		Braak tangle stage IV 				1		0	"Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
TDP43opathy (Present) [+Ndgen.TDP], "	Tau Braak IV and localised TDP-43 cytoplasmic inclusions in the hippocampus and adjacent parahippocampal gyrus			1a. Chronic obstructive pulmonary disease				BA9, Nigra											
	BBN002.28121	A448/15, 		NM-581		Control		Control case		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			79	M	unknown					53				Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 2 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 2 (Present) [+Ndgen.Thal2], "	Mild age-related changes (PART) BNE II, possible control; Mild small vessel disease; Very mild cerebral amyloid angiopathy	"APOE=3/4
"		End stage polycystic kidney disease			"
BDR data indicates:
Drugs:{
Alfacalcidol, Amlodipine, DialyVit tablets, Diltiazem, Eprex, Ferrous Fumarate, Ferrous Sulphate, Furosemide, Lanthanum, Levothyroxin, Levothyroxine, Omeprazole, one alpha, Quinine Sulphate, Ramipril, Renauit, Sodium Bicarbonate, Tamsulosin
}
Indications:{
-, BP, Cramp, Iron, Iron supplement, Kidney, Oesophagatis, thyroid hormone, Unknown, Urinary Flow, Water retention}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.28412	A017/16, 		NM-582		MSA-P				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			94	F	White (European)	158	60			29		6.82		Braak tangle stage IV 				1		0	"Cerebrovascular disease (Present) [+CVD], 
Capillary CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.CapCAA], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], "	Cerebrovascular disease, Cerebral amyloid angiopathy, capillary type; Alzheimer's Disease BNE stage 4							BA9, Nigra											
	BBN002.28414	A006/16, 		NM-583		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			68	F	White (European)					58.5		6.56		Braak tangle stage II 				1		0	"No abnormality detected (Present) [+NAD], 
Braak tangle stage II (Present) [+Ndgen.BandBII], "	Control case: modified Braak (BNE) stage AD stage 2 with mild focal amyloid angiopathy							BA9, Nigra											
	BBN002.28709	A142/16, 		NM-584		Control		"Control case.
Reported hypertension in 2014 and stroke in 2015"		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			83	M	unknown	170	71			48				Braak tangle stage II 				1		0	Braak tangle stage II (Present) [+Ndgen.BandBII], 	Tau Braak stage II consistent with ageing process, control			Cardiac arrest				BA9, Nigra											
	BBN002.28767	A154/16, 		NM-585		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				99	F	White (European)	152	59.9			46			1178					1		0	"A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta], 
Tauopathy, non-Alzheimer's (Present) [+Ndgen.NonADTau], "	Amyloid angiopathy, Pre beta amyloid Thal stage 3 and Tau Braak stage 2-3			1a. Pneumonia			CO-AMOXICLAV	BA9											
	BBN002.28858	A237/16, 		NM-586		Control		some memory problems consistent with ageing		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			80	M	White (European)					58			1222	Braak tangle stage I 				1		0	"No abnormality detected (Present) [+NAD], 
Braak tangle stage I (Present) [+Ndgen.BandBI], "	consistent with ageing process, control	"APOE=3/3
"		cancer			"ferrous sulfate
nitrofurantoin
aspirin
atorvastatin
bisoprolol
lansoprazole
losartan
oxybutynin
senna
aspirin


   "	BA9, Nigra											
	BBN002.29054	A294/16, 		NM-587		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			94	F	White (European)					38			1031					1		0	AD not otherwise specified (Present) [+Ndgen.AD.ADNOS], 	Alzheimer's disease pathology (with skipped areas and corresponding to modified Braak (BNE) stage 6 but with no known history of cognitive decline)			1a. Metastatic cancer endometrium 2. Senescence				BA9, Nigra											
	BBN002.29089	A297/16, 		NM-588		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				81	M	White (European)	165	48			10			1244	Braak tangle stage I 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Braak tangle stage I (Present) [+Ndgen.BandBI], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	Early Alzheimer's changes, in keeping with BNE stage 1, with very mild amyloid angiopathy, control	"APOE=3/3
"		1a. Metastatic prostate cancer			"presnisolone 40mg

BDR data indicates:
Drugs:{
Bicalutamide, bicolutamide, Tamoxifen, vitamin D
}
Indications:{
prostate cancer, side effects of prostate cancer treatment}
: Further data is available from BDR.
"	BA9											
	BBN002.29170	A354/16, 		NM-589		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			92	F	White (European)	171	40			12			1079	Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	Early Alzheimer type changes, BNE stage 2; mild small vessel disease	"APOE=3/3
"		1a. Old age 2. dementia				BA9, Nigra											
	BBN002.29402	A309/16, 		NM-590		Control		bipolar/mental health issues		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			60	F	White (European)	173	144			33			1168	Braak tangle stage I 				1		0	"No abnormality detected (Present) [+NAD], 
Braak tangle stage I (Present) [+Ndgen.BandBI], "	Consistent with ageing. No evidence of degenerative disease 			1a. Carcinomatosis 1b. Endometrial cancer 2. Type 2 Diabetes				BA9, Nigra											
	BBN002.29416	A382/16,		NM-591		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			87	M	unknown					48			1169	Braak tangle stage I 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 2 	1		0	"Severe arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.SevCAA], 
Braak tangle stage I (Present) [+Ndgen.BandBI], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 2 (Present) [+Ndgen.Thal2], "	"control case (but with moderate to severe amyloid angiopathy)
Braak BNE stage 1"	"APOE=3/4
"		1a. Cardiac Failure			"
BDR data indicates:
Drugs:{
Aspirin, Asprin, Candesartan, Carvedilol, Eplerenone, Frusemide, Furosemide, Furosomide, irinAs, Mometasone, Nicorandel, Nicorandil, pravastatin, Salbutamol, Simvastatin
}
Indications:{
Angina, beta blocker, Beta blockers, Blood Pressure, Cholesterol, Heart failure, Heart faliure, heart regulation, inhalor, nasal spray}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.29471	A446/16, 		NM-592		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			70	F	White (European)	165				55			1232	Braak tangle stage I 				1		0	Braak tangle stage I (Present) [+Ndgen.BandBI], 	"Acute myeloid leukaemia
Very early ageing changes (BNE stage I; very mild cerebral amyloid angiopathy)"	"APOE=3/3
"		1a. Acute myeloid leukaemia 2. hypertension			"

   "	BA9, Nigra											
	BBN002.29472	A360/16, 		NM-593		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			86	M	White (European)	191.5	97			56			1441	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 2,  Brain stem Lewy body disease, 	Thal phase 0 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 2 (Present) [+Ndgen.Mov.Synuc.LB2], 
Brain stem Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBBS], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	Brain stem stage Lewy body pathology (subclinical Pakinson's disease)	"APOE=2/3
"					"
BDR data indicates:
Drugs:{
Ascorbic acid, Candastaran, Digoxin, dutasteride, felodipine, Ferrous Fumarate, ferrous fumerate, Finasteride, Furosemide, Omeprazole, omiprazoc, viazem, warfarin
}
Indications:{
acidviazem, aerial fibrilation, atrial fibbrulation, Blood pressure, gastroresistant, iron absorption, iron deficiency, nk, Prostate enlargement, stroke prevention, water retention}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.29498	A376/16, 		NM-594		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			75	F	White (European)					58			1290	Braak tangle stage IV 	CERAD moderate density of neuritic plaques 	Braak LB stage 0, 	Thal phase 4 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD moderate density of neuritic plaques (Present) [+Ndgen.CERAD2], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 4 (Present) [+Ndgen.Thal4], "	"Intermediate probability of Alzheimer's disease, BNE stage IV
Metastatic carcinoma in keeping with breast origin"	"APOE=3/3
"		terminal cancer			"matrifen 12mg

BDR data indicates:
Drugs:{
Metoclopramide, Omeprazole, Oxycodene, Tamoxifen, Ventolin Inhaler
}
Indications:{
-, cancer, Hiatus Hernia, pain, side effect = nausea}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.29730	A541/16, 		NM-595		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			91	F	White (European)					29			1145	Braak tangle stage II 				1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
Metastatic tumours (Present) [+Neopl.Mets], "	"metastatic adenocarcinoma
Azheimer type pathology, BNE stage 2
mild to moderate amyloid angiopathy
"	"APOE=3/3
"					"

   "	BA9, Nigra											
	BBN002.29839	A516/16, 		NM-596		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			81	F	White (European)					64			1192	Braak tangle stage IV 		Brain stem Lewy body disease, 		1		0	"Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
Brain stem Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBBS], 
Trauma (Present) [+Trauma], 
TDP43 pathology accompanying AD/ other disease/ ageing (Present) [+Ndgen.TDP.TDPaccomp], "	"Small old infarct in the right cerebellum
Tau braak stage 4 and focal alpha-synuclein (brainstem) and TDP-43 pathology"			1a. End stage chronic obstructive pulmonary disease 2. Ischeamic heart disease, atrial fibrilliation				BA9, Nigra											
	BBN002.30075	A103/17, 		NM-597		Control		"control
Vasculitis
Auto-imune disease"		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			55	F	White (European)		113			71			1146	Braak tangle stage 0 				1		0	Braak tangle stage 0 (Present) [+Ndgen.BandB0], 	Control (modified Braak stage 0/+ at most)			1a. Multi Organ Failure 1b Severe Sepsis 1c bronchopneumonia 2 Mixed connective tissue disease, Ischaemic heart disease			"azathioprine
allopurinol
"	BA9, Nigra											
	BBN002.30078	A096/17, 		NM-598		Control		reports of worsening short term memory		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			85	F	White (European)					44			1030					1		0	AD not otherwise specified (Present) [+Ndgen.AD.ADNOS], 	Alzheimer's disease pathology (posterior cortical type)			1a. Malignant neoplasm of pancreas 2. Congestive cardiac failure, bronchiectasis			"macrogois
cyclizine
sodium docuste
metoclopramide
haloperidol
mitrazapine"	BA9, Nigra											
	BBN002.30131	A193/17, 		NM-599		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			97	M	White (European)					40			1352	Braak tangle stage IV 	CERAD moderate density of neuritic plaques 	Braak LB stage 0, 	Thal phase 5 	1		0	"Mild arteriolar A√ü-CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.MildCAA], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD moderate density of neuritic plaques (Present) [+Ndgen.CERAD2], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 5 (Present) [+Ndgen.Thal5], "	"Alzheimer's disease pathological features ((modified Braak (BNE) stage 4) with mild amyloid angiopathy
"	"APOE=3/3
"		1a. Lower respiratory infection 1b. Old age and frailty			"
BDR data indicates:
Drugs:{
Antacid, Omeprazole
}
Indications:{
anti-acid, stomach}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.30139	A234/17, 		NM-600		Control	Control	Lacunar infarct		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			47	F	White (European)					26		5.66	1087					1		0	No abnormality detected (Present) [+NAD], 	"Mild dilation of perivascular spaces in putamen, otherwise unremarkable.
There is no evidence of neurodegenerative disease"			1a. End stage renal failure 1b. Diabetic nephropathy 1c. Diabetes mellitus 2.small bowel perforation				BA9, Nigra											
	BBN002.30154	A229/17, 		NM-601		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			91	M	unknown					41.5			1317	Braak tangle stage IV 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 3 	1		0	"Capillary CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.CapCAA], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 3 (Present) [+Ndgen.Thal3], "	AGD, Alzheimer type changes, in keeping with BNE stage IV, Moderate cerebral amyloid angiopathy (capillary type).	"APOE=3/3
"		1a. Acute Myocardial Infarction 1b. Ischaemic Heart Disease II Hypertension, Hypercholesterolaemia			"
BDR data indicates:
Drugs:{
12 hr modifed release diltiazen, Adcal D3, alendronic acid, atorvastatin, bisoprolol, iboprofen gel, isosorbide mononitrate, Laxido orange, maxitrol eye drops, omeprazole, Paracetamol, spironolactone, warfarin, warfarin 1mg, zopiclone
}
Indications:{
anit-inflammatory, atrial fibrillation, blood thinning, bone density, calcium channel blocker, cholesterol, constipation, hypnotic, pain relief}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.30167	A247/17, 		NM-602		Control		"F06.7
Mild cognitive disorder"		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			108	F	White (European)	160	60			68			1129	Braak tangle stage II 	CERAD sparse neuritic plaques 	Brain stem Lewy body disease, 		1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Brain stem Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBBS], 
Aging-related tau-astrogliopathy (ARTAG) (Present) [+Ndgen.NonADTau.ARTAG], 
TDP43 pathology accompanying AD/ other disease/ ageing (Present) [+Ndgen.TDP.TDPaccomp], "	Lewy body pathology (Brain stem stage) (Braak Lewy body stage 1), limbic TDP-43 pathology (Joseph stage 1). ARTAG pathology and mild AD pathology (modified Braak/BNE stage 2)			1a. Bronchopneumonia 2. old age			"diazepam
levomepromazine
midazolam
hypscine butylbromide
amoxicillin
latanoprodt
"	BA9, Nigra											
	BBN002.30171	A256/17, 		NM-603		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				86	F	White (European)					27			1210	Braak tangle stage II 	CERAD sparse neuritic plaques 		Thal phase 2 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Thal phase 2 (Present) [+Ndgen.Thal2], "	control case-age related changes and very mild Alzheimer's disease pathology (modified Braak/BNE stage 2)	"APOE=3/3
"		1a. Idiopathic Pulmonary Fibrosis 2. pulmonary hypertension			"aspirin
atenotol
lorsartan
felodipine
gycerol
simvastatin
omeprazole


   "	BA9											
	BBN002.30188	A275/17, 		NM-604		Control		"sudden onset of difficulties with memory following accident in July 2013 (lost consciousness during a fall on a bus)
dysphagia
"		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			94	F	White (European)	152	46			45			1070	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Capillary CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.CapCAA], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	Moderate small vessel disease and moderate cerebral amyloid angiopathy of capillary type, moderate risk of contributing to dementia (VCING)	"APOE=3/3
"		1a. Squamous cell cancer of oesophagus			"
BDR data indicates:
Drugs:{
Atenolol
}
Indications:{
Blood pressure}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.30828	A338/17, 		NM-605		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			86	F	unknown					59			1318	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 2 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 2 (Present) [+Ndgen.Thal2], "	Early Alzheimer type changes, BNE stage II	"APOE=3/3
"					"
BDR data indicates:
Drugs:{
amlopodine, Aspirin, atorvastatin, bisoprolol, calcium carbonate, furosemide, losartan, omeprazole, omeprezole, simvastatin
}
Indications:{
blood thinner, bp, cholesterol, reflux, uncertain}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.30848	A366/17, 		NM-606		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			97	M	White (European)					25			1414	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	"hydrocephalus ex vacuo, primary age-related tauopathy (BNE stage 2)
Old cerebellar infarct"	"APOE=3/3
"		1a. Aspiration Pneumonia 2. Cerebrovascular Accident, Hypertension			"rivaroxaban
midazolam
morphine sulfate

BDR data indicates:
Drugs:{
aspirin, bendroflumethiazide, docusate, docusate sodium, FERROUS GLUCONATE, frusemide, Furosemide, oxybutynin, paracetamol, QUININE SULPHATE, Ramipril, Senna, SIMVASTATIN, Simvistatin, Tamsulosin, vesicare
}
Indications:{
BP, CHOLESTEROL, CRAMPS, DK, HEART}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.30852	A371/17, 		NM-607		PD		PD (20 year history)		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			71	M	White (European)					46			1432	Braak tangle stage I 	CERAD sparse neuritic plaques 	Braak LB stage 6,  Neocortical Lewy body disease, 	Thal phase 1 	1		0	"Braak tangle stage I (Present) [+Ndgen.BandBI], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Progressive supranuclear palsy, movement disorder (Present) [+Ndgen.Mov.NonADTau.PSP], 
Braak LB stage 6 (Present) [+Ndgen.Mov.Synuc.LB6], 
Neocortical Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBNeoc], 
Progressive supranuclear palsy (Present) [+Ndgen.NonADTau.PSP], 
Thal phase 1 (Present) [+Ndgen.Thal1], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], "	"Diffuse Lewy body disease, mild neocortical subtype (McKeith)
Progressive supranuclear palsy"			brochopnuemonia				BA9, Nigra											
	BBN002.30886	A402/17,		NM-608		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			78	F	White (European)	166	72			6.5			1187	Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	"Primary Age related tauopathy (PART) BNE stage 1-2
Mild small vessel disease"	"APOE=3/3
"		Renal failure 			"

   "	BA9, Nigra											
	BBN002.30920	A435/17, 		NM-609		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			68	F	White (European)					64				Braak tangle stage 0 	CERAD no plaques 		Thal phase 3 	1		0	"Braak tangle stage 0 (Present) [+Ndgen.BandB0], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Thal phase 3 (Present) [+Ndgen.Thal3], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], "	"very early ageing changes, Thal phase 3, BNE stage +
mild small vessel disease"	"APOE=3/3
"		Follicular lymphoma 				BA9, Nigra											
	BBN002.31494	A485/17, 		NM-610		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			84	M	unknown	178	57.9			32			1480	Braak tangle stage IV 	CERAD high density of neuritic plaques 		Thal phase 5 	1		0	"Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD high density of neuritic plaques (Present) [+Ndgen.CERAD3], 
Thal phase 5 (Present) [+Ndgen.Thal5], "	Moderate Alzheimer's disease pathology with moderate amyloid angiopathy			1a. Carcinatosis 1b. Carcinoma of the pancreas				BA9, Nigra											
	BBN002.32537	A551/17, 		NM-611		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				89	M	unknown	184	72.4			41			1330	Braak tangle stage II 	CERAD no plaques 		Thal phase 0 	1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Moderate/severe arteriosclerosis in occipital white matter (absent) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (absent) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	Normal Ageing process							BA9											
	BBN002.32539	A552/17, 		NM-612		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			98	M	unknown					29			1179	Braak tangle stage II 	CERAD sparse neuritic plaques 		Thal phase 3 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Thal phase 3 (Present) [+Ndgen.Thal3], "	"Pathological ageing with mainly Alzhiemers type changes BNE stage 3-4
Amyloid angiopathy of capillary type in the occipital lobe, prominent small vessel disease, moderate risk VCING"	"APOE=3/4
"		1a. metastatic prostate cancer			"BDR data indicates:
Drugs:{
Alendronic Acid, Aspirin, Bendroflumethiazide, Lercandipine, Lercanidibine, Omeprazole
}
Indications:{
Gastric Reflux, Hypertenstion, Osteoporosis, TIA}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.32551	A012/18, 		NM-613		PSP		"PSP
CBD
bvFTD"		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			63	F	White (European)					36			883	Braak tangle stage IV 	CERAD no plaques 		Thal phase 0 	1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Globular glial tauopathy (Present) [+Ndgen.NonADTau.FTLD.GGT], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Moderate/severe arteriosclerosis in occipital white matter (absent) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (absent) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	Atypical 4-repeat tauopathy, mixed features between CBD and GGT			1a PSP				BA9, Nigra											
	BBN002.32580	A037/18, 		NM-614		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			98	M	unknown					58			1357	Braak tangle stage III 	CERAD moderate density of neuritic plaques 		Thal phase 4 	1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Braak tangle stage III (Present) [+Ndgen.BandBIII], 
CERAD moderate density of neuritic plaques (Present) [+Ndgen.CERAD2], 
Thal phase 4 (Present) [+Ndgen.Thal4], 
Moderate/severe arteriosclerosis in occipital white matter (absent) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (absent) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"Alzheimer type changes in keeping with BNE stage III
Very mild cerebral amyloid angiopathy"	"APOE=3/4
"		1a. old age 			"
BDR data indicates:
Drugs:{
Amiodarone, amlodopine, aspirin, astorvastatin, atorvastatin, citalopram, Citalopram Hydrobromide, fluoxetine hydrochloride, frusemide, furosemide, levothyroxine, losartan, omeprazole, Over 2 years, tamsulosin, Tamsulosin Hydrochloride
}
Indications:{
arrythmia, blood pressure, cholesterol, depression, diuretic/heart problem, heart, Pain killers, Prostate}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.32584	A041/18, 		NM-615		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				98	F	White (European)					24.5			1109	Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], "	"Early Alzheimer type changes, BNE stage 2
Mild to moderate cerebral amyloid angiopathy, Mild to moderate small vessel disease"	"APOE=2/3
"		1a. bronchopneumonia			"taethason valuerate
blephasol
ensure compact

   "	BA9											
	BBN002.32590	A046/18, 		NM-616		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			81	F	unknown					24			1200	Braak tangle stage II 	CERAD no plaques 		Thal phase 3 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Thal phase 3 (Present) [+Ndgen.Thal3], "	Control case but with extensive amyloid angiopathy			1a Infective exacerbation of COPD 2 frailty of old age			"LEFLUNOMIDE
CO-CODAMOL
DOXYCLCLINE
CALCIUM
Vit D
INHALERS"	BA9, Nigra											
	BBN002.32628	A080/18,		NM-617		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			93	M	unknown					26			1215	Braak tangle stage V 	CERAD moderate density of neuritic plaques 		Thal phase 2 	1		0	"Braak tangle stage V (Present) [+Ndgen.BandBV], 
CERAD moderate density of neuritic plaques (Present) [+Ndgen.CERAD2], 
Thal phase 2 (Present) [+Ndgen.Thal2], "	Intermediate probability of dementia due to Alzheimer's disease	"APOE=3/3
"		Discitis			"

   "	BA9, Nigra											
	BBN002.32633	A083/18, 		NM-618		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			81	F	White (European)					26.5			1178	Braak tangle stage III 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 2 	1		0	"Infarct/s >10 mm in diameter (absent) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage III (Present) [+Ndgen.BandBIII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 2 (Present) [+Ndgen.Thal2], 
Moderate/severe arteriosclerosis in occipital white matter (absent) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (absent) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"Early Alzheimer type changes BNE stage 2; possible control
Lacunar infarct in the pons, secondary to atherosclerosis"	"APOE=3/3
"		1a. Carcinoma of the lung			"

   "	BA9, Nigra											
	BBN002.32803	A097/18,		NM-619		Control		Control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			85	F	unknown					29.5			1315	Braak tangle stage III 	CERAD sparse neuritic plaques 		Thal phase 2 	1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Braak tangle stage III (Present) [+Ndgen.BandBIII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Thal phase 2 (Present) [+Ndgen.Thal2], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], "	Marked small vessel disease, Alzheimer type changes (BNE stage II), mild to moderate cerebral amyloid angiopathy	"APOE=3/3
"		1a Aspiration pneumonia 2 bowel obstruction			"
BDR data indicates:
Drugs:{
Amlodipine, aspirin, Atenolol, atorvastatin, calcium - calcichew D3, calcium + vitamin dx2, colecal, latanaprost, Latanoprost, Losartan, movical, movicol, Musocol, solifenacin, xalatan/latanoprost
}
Indications:{
beta-blockers, blood thinner, calcium, Cholesterol, constipation, eyes, gaucoma, Glaucoma, statins}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.32805	A104/18, 		NM-620		Control		Control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			90	M	unknown					28			1296	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 5,  Limbic Lewy body disease, 	Thal phase 1 	1		0	"Infarct/s >10 mm in diameter (absent) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 5 (Present) [+Ndgen.Mov.Synuc.LB5], 
Limbic Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBLim], 
Thal phase 1 (Present) [+Ndgen.Thal1], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (absent) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	Lewy body pathology amounting to limbic stage, no dementia clinically and no Parkinsonian features	"APOE=2/3
"		1a Pneumonia 2 Congestive cardiac failure, acute renal failure			"BDR data indicates:
Drugs:{
Ambien, Amlodipine, amlodopine, Asacol, Asacol MR, aspirin, Asprin, Beclomethasone, Bendroflumethiazide, Betamethasonevalarate, betamethazone, Diclofenac, Diclofenac Sodium, Docusate, Doxazosin, Fentanyl, Finasteride, Hydrocortisone, lactulose, Losartan, OCTASA, omeprazole, paracetamol, Paracetemol, Senna, Senna`, Seretide, Seretide 500, simvastatin, temazapan, Temazepam, tramadol, Xatral
}
Indications:{
allergy, asthma, Blood Pressure, BP, cholesterol, colitis, Colitis?, constipation, difficulty passing urine, difficulty sleeping, dry skin, Hypertension, Laxative, pain relief, SINCE STROKE, Sleep, stomach trouble, Ulcerotheritiis}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.32844	A141/18, 		NM-621		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			81	F	White (European)	164	43			42			1081	Braak tangle stage 0 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Braak tangle stage 0 (Present) [+Ndgen.BandB0], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], "	Normal brain consistent with patients age						"BDR data indicates:
Drugs:{
Aclidinium inhalationspulver, Mucodyne
}
Indications:{
COPD}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.32855	A153/18, 		NM-622		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				95	F	White (European)					40				Braak tangle stage IV 	CERAD high density of neuritic plaques 		Thal phase 5 	1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD high density of neuritic plaques (Present) [+Ndgen.CERAD3], 
Thal phase 5 (Present) [+Ndgen.Thal5], 
TDP43 pathology accompanying AD/ other disease/ ageing (Present) [+Ndgen.TDP.TDPaccomp], "	"Intermediate probability of Alzheimer's disease, BNE stage IV
Mild small vessel disease and mild cerebral amyloid angiopathy"	"APOE=3/4
"		pneumonia, heart failure			"BDR data indicates:
Drugs:{
Homeopathic '3cs', Kelp, Tryptophan
}
: Further data is available from BDR.
"	BA9											
	BBN002.32914	A183/18, 		NM-623		Control		Control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			86	F	unknown					38			921	Braak tangle stage VI 	CERAD high density of neuritic plaques 	Limbic Lewy body disease, 	Thal phase 5 	1		0	"Infarct/s >10 mm in diameter (absent) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage VI (Present) [+Ndgen.BandBVI], 
CERAD high density of neuritic plaques (Present) [+Ndgen.CERAD3], 
Limbic Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBLim], 
Thal phase 5 (Present) [+Ndgen.Thal5], 
TDP43 pathology accompanying AD/ other disease/ ageing (Present) [+Ndgen.TDP.TDPaccomp], "	Alzheimer's disease pathology (modified Braak/BNE stage VI) with extensive angiopathy, limbic TDP-43 pathology and amygdala only Lewy body pathology	"APOE=3/4
"					"
   "	BA9, Nigra											
	BBN002.32916	A184/18, 		NM-624		CBD	CBD			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			73	M	unknown					46			1096					1		0	Corticobasal degeneration (Present) [+Ndgen.NonADTau.CBD], 	"4- repeat Tauopathy favouring Corticobasal Degeneration (CBD) with motor cortex and spinal cord involvement
"			1a. Pneumonia 2. CBD				BA9, Nigra											
	BBN002.33637	A234/18, 		NM-625		Control		control		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			100	F	unknown					68			947	Braak tangle stage II 	CERAD no plaques 		Thal phase 0 	1		0	"Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], "	"Limbic tauopathy, strongly suggestive of Argyrophilic Grain Disease (BNE stage II)
Moderate small vessel disease and occipital amyloid angiopathy"	"APOE=3/3
"		1a. old age			"BDR data indicates:
Drugs:{
Adcal D3, Amlodopine, Aspirin, Citalopram, furosemide, lisinopril, lorazepam, paracetemol, Ranitidine, senna
}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.33688	A302/18, 		NM-626		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			90	F	unknown	160	56			30			981	Braak tangle stage II 	CERAD sparse neuritic plaques 		Thal phase 2 	1		0	"Infarct/s >10 mm in diameter (absent) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Thal phase 2 (Present) [+Ndgen.Thal2], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], 
Braak LB stage not assessed (Present) [+Ndgen.Mov.Synuc.na], "	control case but extensive amyloid angiopathy			1a) Multi organ failure 1b) old age			"BDR data indicates:
Drugs:{
Cetirizine, domperidone, Paracetemol, Propranolol, zopiclone
}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.33741	A351/18, 		NM-627		MSA-P		MSA		KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			67	M	unknown					25			1417	Braak tangle stage I 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Infarct/s >10 mm in diameter (absent) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage I (Present) [+Ndgen.BandBI], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Moderate/severe arteriosclerosis in occipital white matter (absent) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (absent) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"Multiple system atrophy
Age related astroglial tauopathy"			1a. Aspiration pneumonia 1b. MSA			"atropine
co careldopa
omeprazole
ranitidine
bramox
entacapone
fludrocortisone
senna
carbocisteine
citalopram
ferrous fumarate
pyridostigmine
hypermellose
cetraban
ventolin
lactulose"	BA9, Nigra											
	BBN002.34087	NA083/02, 		NM-628		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				83	F						24						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34088	NA084/02, 		NM-629		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				83	M						37						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34089	NA085/02, 		NM-630		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				75	M						36						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34093	NA088/02, 		NM-631		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				82	M						24						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34094	NA089/02, 		NM-632		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				73	F						60						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34095	NA090/02, 		NM-633		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				80	F						28						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34096	NA091/02, 		NM-634		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				81	F						48						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34097	NA092/02, 		NM-635		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				78	M						24						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34099	NA094/02, 		NM-636		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				80	M						50						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34100	NA097/04, 		NM-637		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				88	M						24						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34101	NA098/04, 		NM-638		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				86	F						24						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34104	NA101/04, 		NM-639		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				88	F						32						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34106	NA164/03, 		NM-640		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				83	F						24						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34107	NA165/03, 		NM-641		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				82	F						33						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34108	NA166/03, 		NM-642		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				79	M						30						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34109	A167/03, 		NM-643		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				72	M						9						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34110	NA168/03, 		NM-644		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				75	F						24						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34111	NA169/03, 		NM-645		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				85	F						36						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34112	NA170/03, 		NM-646		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				84	F						27						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34114	ST30/04, 		NM-647		PD				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+				86	M						32						Parkinson's/Lewy body findings, 		1		0	Parkinson's/Lewy body findings (Present) [+Ndgen.Mov.Synuc.LB], 	Parkinson's Disease, Dementia							BA9											
	BBN002.34129	A394/18, 		NM-648		Control	Vascular disease, mild signs of AD and TDP-43			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			96	F	unknown	163	39			36		6.22	1190	Braak tangle stage II 		Braak LB stage 0, 	Thal phase 1 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], 
TDP43 pathology accompanying AD/ other disease/ ageing (Present) [+Ndgen.TDP.TDPaccomp], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	Mild cerebrovascular disease, VCING score low with very mild Alzheimer disease pathology (Modified Braak stage I-II) and with limbic and early cortical TDP-43 pathology			"1a) Arterial embolus with ischaemic leg 
1b) arterial fibrillation
2) valvular heart disease"			"BDR data indicates:
Drugs:{
Bendroflumethiazide, Bisacodyl, Bisoporolol, Bisoprolol, Bisoprolol Fumerate, Bumetanide, Co-amilofruse, HRT, Macrogol, Omeprazole, Premarin, Ramipril, Spironolactone, Warfarin
}
Indications:{
Betablocker for heart, Blood thinner, Diretic, HRT, Menopause, Stomach}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.34132	A399/18, 		NM-649		Control				KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			97	F	unknown	176	56			4			1062	Braak tangle stage IV 	CERAD moderate density of neuritic plaques 	Braak LB stage 0, 	Thal phase 5 	1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Braak tangle stage IV (Present) [+Ndgen.BandBIV], 
CERAD moderate density of neuritic plaques (Present) [+Ndgen.CERAD2], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 5 (Present) [+Ndgen.Thal5], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"Cerebrovascular disease (severe amyloid angiopathy, severe large vessel disease, moderate small vessel disease)
Extensive old cystic infarcts, intermediate probability of Alzheimer's disease, BNE stage IV"			1a. Old age 2. cerebrovascular accidents			"BDR data indicates:
Drugs:{
Apixaban, aspirin, atorvastatin, bisoprolol, Ferrous farmarate, Ferroy sulphate, ferusomide, Furosemide, Latinoprost, losartan potassium, Loscartin, Losurtan, Paracetamol, Preservision, sertraline, Simvastatin, Warfarin
}
Indications:{
blood thinner, cholesterol}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.34143	A413/18, 		NM-650		control	Lymphoma			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			75	F	White (European)	162	44			42		5.87	1121	Braak tangle stage I 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 3 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage I (Present) [+Ndgen.BandBI], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 3 (Present) [+Ndgen.Thal3], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"White matter lesions favouring a viral process possible Progressive Multifocal leukoencephalopathy (PML) with intravascular lymphoid cells, possibly residual lymphoma
Braak/BNE stage I, Thal 3, CERAD Low A2B1C0"			1a. Mantle cell lymphoma 			"BDR data indicates:
Drugs:{
Aceclofenac, Aciclovir, Adcal D3, Adcal-D3, Alginate suspension, Allopurinol, Amiloride, Atorvastatin, Calcium carbonate, Domperidone, Folic acid, Fortisip, Furosemide, Hypomellose eye drops, Hypromellose, lactulose, Meloxicam NSAID, Meptazinol, Morphine Sulphate, Omeprazole, Ondansetron, Paracetamol, Ranitidine, Senna, Zomorph MR, Zopiclone
}
Indications:{
Aches, n/a}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.35103	A509/18, 		NM-651		MSA	MSA			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			75	M	White (European)					22				Braak tangle stage II 	CERAD no plaques 	Brain stem Lewy body disease, 	Thal phase 0 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Brain stem Lewy body disease (Present) [+Ndgen.Mov.Synuc.LBBS], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Primary age related tauopathy (PART) (Present) [+Ndgen.NonADTau.PART], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"Multiple System Atrophy (mixed subtype)
Braak BNE stage II, Thal 0, CERAD 0 A0B1C0, Low VCING"			1a. MSA				BA9, Nigra											
	BBN002.35107	A491/18, 		NM-652		control	"Primary age-related tauopathy (PART)
acute infarction in the left parietal lobe"			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			72	M	unknown					36		5.92	1442	Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"Primary age-related tauopathy (PART)
acute infarction in the left parietal lobe"			1a. Mulit-organ failure/sepsis			"BDR data indicates:
Drugs:{
ASPIRIN, ATENOLOL, PRAVASTATIN, RAMIPRIL
}
Indications:{
ANTIPLATELET, BLOOD PRESSURE, CARDIO, STATINS}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.35133	A531/18, 		NM-653		control	Old infarcts and microinfarcts, Primary Ageing Related Tauopathy, BNE stage II			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			91	F	unknown					26		6.11	1107	Braak tangle stage II 	CERAD no plaques 	Braak LB stage 0, 	Thal phase 0 	1		0	"Infarct/s >10 mm in diameter (Present) [+CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	Old infarcts and microinfarcts, Primary Ageing Related Tauopathy, BNE stage II			1a. pulmonary embolisis, 2. crest syndrome			"BDR data indicates:
Drugs:{
Co-dydramol, Domperidome, Lansoprazole, Loperamide, Nexium , Omeprazole, Oxybutynin, PARACETAMOL
}
Indications:{
bowel, Bowel meds , Gastric reflux, Heart burn, Heart burt, Indigestion, Overactive bladder, Pain}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.35136	A535/18, 		NM-654		CBD	4-repeat tauopathy with unusual white matter (glial cell) predominance 			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			77	F	White (European)	153	61.2			69		6.59	1319	Braak tangle stage I 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 3 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage I (Present) [+Ndgen.BandBI], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 3 (Present) [+Ndgen.Thal3], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	4-repeat tauopathy with unusual white matter (glial cell) predominance 			1a.  end stage dementia/ AD				BA9, Nigra											
	BBN002.35137	A540/18, 		NM-655		control	control case (Alzheimer's disease pathology- modified Braak/BNE stage 2)			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			80	F	White (European)					57		6.19	1191	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 1 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 1 (Present) [+Ndgen.Thal1], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	control case (Alzheimer's disease pathology- modified Braak/BNE stage 2)			1a. Myocardial infarction 1b. Ischaemic heart disease 2. gastrointestinal bleed, hypertension			"BDR data indicates:
Drugs:{
Alendronic Acid, Amitriptyline, Amlodipine, Apirin, Aspirin, Atorvastatin, Beclometasone, Bisoprolol, Clopidogerel, Clopidogrel, Colecalciferol, Ferrous sulphate, Incruse Ellipta, Iputropium bromide, Lansoprosole, Lisinopril, Oprigabalin, Paracetamol, Reldar Ellipta, Rivaorixadan, Seretide, Tramadol, Tramaprost
}
Indications:{
BP/Angina, Cholseterol, Depression, n/k, osteoporosis}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.35141	A548/18,		NM-656		control	"mild to moderate cerebrovascular disease with mild limbic TDP-43 pathology
Tau Braak/BNE stage II, Thal 2, A1B1C1, Mod VCING"			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			91	F	unknown					20		6.02	1143	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 2 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 2 (Present) [+Ndgen.Thal2], 
TDP43 pathology accompanying AD/ other disease/ ageing (Present) [+Ndgen.TDP.TDPaccomp], 
Moderate/severe arteriosclerosis in occipital white matter (Present) [+CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (Present) [+CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"mild to moderate cerebrovascular disease with mild limbic TDP-43 pathology
Tau Braak/BNE stage II, Thal 2, A1B1C1, Mod VCING"			1a. Lymphoma			"BDR data indicates:
Drugs:{
adcal-D3 chewables, betahistine dihydrochloride, betahistine dihydrocholoride, levothryroxine, Levothyroxine, minims artificial tear eye drops
}
Indications:{
balance issues, calcium, dizziness, dry eye, no thyroid gland, thryoidectomy, thyroid}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.35212	A054/19, 		NM-657		control	Cerebrovascular disease (marked SVD), Alzheimer's disease, BNE stage II, A3B1C1, no VCING, Thal 4			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			87	F	White (European)					47		6.13	1098	Braak tangle stage II 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 4 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 4 (Present) [+Ndgen.Thal4], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	Cerebrovascular disease (marked SVD), Alzheimer's disease, BNE stage II, A3B1C1, no VCING, Thal 4			1a. Cancer of head of pancreas with metastatises to lung			"BDR data indicates:
Drugs:{
Alendronic Acid, AMLODIPINE, ASPIRIN, CALCIUM, ENALAPRIL, ENALAPRIL MALEATE, enapril, SIMVASTATIN, statin
}
Indications:{
blood pressure, BONES, BP, CHOLESTEROL, DK, N/A, osteoperosis, OSTEOPOROSIS}
: Further data is available from BDR.
"	BA9, Nigra											
	BBN002.35216	A062/19, 		NM-658		control	"Alzheimer type changes BNE stage III, Mild cerebral amyloid angiopathy, capillary type
Mild small vessel disease, Thal 5, A3B2C1 Low VCING"			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			79	F	White (European)					9		5.96	1268	Braak tangle stage III 	CERAD sparse neuritic plaques 	Braak LB stage 0, 	Thal phase 5 	1		0	"Braak tangle stage III (Present) [+Ndgen.BandBIII], 
CERAD sparse neuritic plaques (Present) [+Ndgen.CERAD1], 
Braak LB stage 0 (Present) [+Ndgen.Mov.Synuc.LB0], 
Thal phase 5 (Present) [+Ndgen.Thal5], "	"Alzheimer type changes BNE stage III, Mild cerebral amyloid angiopathy, capillary type
Mild small vessel disease, Thal 5, A3B2C1 Low VCING"			1a. diabetic nephropathy 2. Ischaemic heart disease, ventricular failure, type 2 diabetes				BA9, Nigra											
	BBN002.35222	A071/19, 		NM-659		control	"Primary age-related tauopathy (PART), BNE stage I-II
Mild amyloid angiopathy (vonsattel grade 1)"			KCL- London Neurodegenerative Diseases Brain Bank	+	-	+	+			78	F	unknown					39		6.32	1555	Braak tangle stage II 	CERAD no plaques 		Thal phase 0 	1		0	"Infarct/s >10 mm in diameter (***ABSENT***) [-CVD.Isch.Ischfo.Infarct], 
Braak tangle stage II (Present) [+Ndgen.BandBII], 
CERAD no plaques (Present) [+Ndgen.CERAD0], 
Thal phase 0 (Present) [+Ndgen.Thal0], 
Moderate/severe arteriosclerosis in occipital white matter (***ABSENT***) [-CVD.Vasc.Arterioscl.OccwmArterioscl], 
Moderate/severe occipital leptomeningeal CAA (***ABSENT***) [-CVD.Vasc.CAA.CAAspont.CAAbeta.OccmeningCAA], "	"Primary age-related tauopathy (PART), BNE stage I-II
Mild amyloid angiopathy (vonsattel grade 1)"			1a. Pulmonary Veno-Occulsive Disease			"BDR data indicates:
Drugs:{
Aspirin, diltiazem, Furosemide, INhaler, Mepradec, Omeprazole, Paracetamol, Riveroxiban, Siodenafal, Slatol
}
Indications:{
Beta Blocker}
: Further data is available from BDR.
"	BA9, Nigra											
	O19/214	O19/214		NM-660		PD				ParkWest			+	+		whole brain	88	M						15			1120																											
	O18/163	O19/163		NM-661		PD				ParkWest	-	+				whole brain	75	M														0		1																				
	A1	R13/149		NM-662		Control				Neuromics Tissue Bank							17.9	F						72															Suicide (hanging)	depression, familiar hypercholesterolemia														
	A13	R14/87		NM-663		Control				Neuromics Tissue Bank							29	F						72															OD (heroin) HCV positive															
	A16	R14/106		NM-664		Control				Neuromics Tissue Bank							27.5	M						20															hanging															
	A17	O14/191		NM-665		Control				Neuromics Tissue Bank							41	F						48															CA mamae, venoocclusive disease															
	C6			NM-666		Control				Neuromics Tissue Bank						Liver	66	M						48			1290												aortic aneurysm operata, complications (2h with systBT 50-60)															
	C7	O11/196		NM-667		Control				Neuromics Tissue Bank		+				Liver, kidney	60	M						35			1730							1					SAH, complications after arterial aneurysm operata right cerebellopontine angle															
	C8			NM-668		Control				Neuromics Tissue Bank						Liver, Ovary	19	F						48																														
	C9			NM-669		Control				Neuromics Tissue Bank						Liver, kidney	53	M						24																														
	C10			NM-670		Control				Neuromics Tissue Bank	+		+			occipital, Liver	0	F						48								1							SIDS							+	+	+						
	C11			NM-671		Control				Neuromics Tissue Bank						Liver, Ovary	21	F																					Found deade in appartment, OD?	IV abuser, hepatitis negative in 2010. Was on methadon and other similar meds. No known diseases.														
	C12	R12/25		NM-672		Control				Neuromics Tissue Bank	+		+			Cerebellum, Liver	0.4	F														1							SIDS							+	+	+						
	C13	R12/28		NM-673		Down's trisomy 21				Neuromics Tissue Bank	+		+			Cerebellum, Liver	0	M														1							SIDS							+	+	+						
	C14	R12/42		NM-674		Control				Neuromics Tissue Bank	+		+			Cerebellum,Ovary	32	F						24								1							Traffic accident	car accident 05.02.2012, coma, respirator since 05.02. CT cerebri: generalized oedema. Organ donation. No known diseases. Had children.														
	C15	O12/127		NM-675		Control				Neuromics Tissue Bank			+			Cerebellum, Ovary, liver	14	F						36															Suicide, hanging															
	C16			NM-676		Control				Neuromics Tissue Bank	+		+			Liver	0.2	M														1							SIDS							+	+	+						
	C17			NM-677		Control				Neuromics Tissue Bank	+		+			Cerebellum, Liver, Ovary	15	F						120								1							Suicide, hanging	Fetal alcohol syndrom, ADHD		concerta, ritalin												
	C18			NM-678		Control				Neuromics Tissue Bank	+		+			Liver, SKM (chest)	0	M						24								1							SIDS							+	+	+						
	C19			NM-679		Control				Neuromics Tissue Bank	+		+	+		Cerebellum, dentate, MO, Ovary	41	F						36								1							Suicide, hanging	depression														
	C22	R12/253		NM-680		Control				Neuromics Tissue Bank	+		+	+			38	M						94								1							Intox															
	C23	R12/258		NM-681		Control				Neuromics Tissue Bank	+		+	+		Cerebellum, dentate, Liver, SKM (psoas)	11	M						48								1							drowning															
	C24	R12/270		NM-682		Control				Neuromics Tissue Bank	+		+			Ovary	31	F						48								1							unknown															
	CF-1	O11/97		NM-683		Control				Neuromics Tissue Bank	-	+					54	M						100			1435					0		1					Hepatitis B (!), cardiac arrest after infarction, pulmonary oedema															
	CF-2	O11/66		NM-684		Control				Neuromics Tissue Bank	-	+	+				47	F						120			1310					0		1					cardiac failure, amyloid, cardiac arrest, myelomatosis															
	CF-4	O11/113		NM-685		Control				Neuromics Tissue Bank	-	+	+				49	M						36			1295					0		1					ca pulm															
		RI06/017		NM-686		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	100	M						72								1		0	Normal aged brain 								PFC, BA46 											
		RI06/053		NM-687		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	71	M						48								1		0	Normal aged brain 								PFC, BA47											
		RI06/057		NM-688		Control	Normal 			Oxford Brain Bank	+	-	+	-	-	-	85	M						48								1		0	Normal 								PFC, BA48											
		RI06/116		NM-689		Control	Normal 			Oxford Brain Bank	+	-	+	-	-	-	89	F						24								1		0	Normal 								PFC, BA49											
		NP07/017		NM-690		Control	Normal 			Oxford Brain Bank	+	-	+	-	-	-	88	M						48								1		0	Normal 								PFC, BA50											
		NP07/055		NM-691		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	86	F						168								1		0	Normal aged brain 								PFC, BA51											
		NP07/082		NM-692		Control	sparse neocrotical neuritic plaques 			Oxford Brain Bank	+	-	+	-	-	-	92	F						96								1		0	sparse neocrotical neuritic plaques 								PFC, BA52											
		NP08/017		NM-693		Control	Control 			Oxford Brain Bank	+	-	+	-	-	-	84	F						48								1		0	Control 								PFC, BA53											
		NP08/049		NM-694		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	87	F						48								1		0	Normal aged brain 								PFC, BA54											
		NP08/072		NM-695		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	84	F						144								1		0	Normal aged brain 								PFC, BA55											
		NP08/094		NM-696		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	80	M						24								1		0	Normal aged brain 								PFC, BA56											
		NP08/158		NM-697		Control	Control 			Oxford Brain Bank	+	-	+	-	-	-	85	M						48								1		0	Control 								PFC, Bag 21 or 24 											
		NP08/168		NM-698		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	71	M						24								1		0	Normal aged brain 								PFC, Bag 21 or 25											
		NP08/217		NM-699		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	82	F						72								1		0	Normal aged brain 								PFC, Bag 21 or 26											
		NP09/052		NM-700		MCI	Normal 			Oxford Brain Bank	+	-	+	-	-	-	92	M						144								1		0	Normal 								PFC, Bag 21 or 27											
		NP09/115		NM-701		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	71	M						24								1		0	Normal aged brain 								PFC, Bag 21 or 28											
		NP10/011		NM-702		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	89	M						72								1		0	Normal aged brain 								PFC, Bag 21 or 29											
		NP10/038		NM-703		Control	Control 			Oxford Brain Bank	+	-	+	-	-	-	93	F						24								1		0	Control 								PFC, Bag 21 or 30											
		NP10/054		NM-704		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	92	M						24								1		0	Normal aged brain 								PFC, Bag 21 or 31											
		NP11/101		NM-705		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	92	F						48								1		0	Normal aged brain 								PFC, Bag 21 or 32											
		NP11/169		NM-706		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	84	F						72								1		0	Normal aged brain 								PFC, Bag 21 or 33											
		NP12/052		NM-707		Control	Normal brain - no specified abnormalities 			Oxford Brain Bank	+	-	+	-	-	-	42	F						48								1		0	Normal brain - no specified abnormalities 								PFC, Bag 21 or 34											
		NP12/083		NM-708		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	62	F						72								1		0	Normal brain 								PFC, Bag 21 or 35											
		NP12/085		NM-709		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	71	F						50								1		0	Normal brain 								PFC, Bag 21 or 36											
		NP12/088		NM-710		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	51	M						23								1		0	Normal brain 								PFC, Bag 21 or 37											
		NP12/094		NM-711		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	63	M						24								1		0	Normal brain 								PFC, Bag 21 or 38											
		NP12/121		NM-712		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	89	F						24								1		0	Normal aged brain 								PFC, Bag 21 or 39											
		NP12/136		NM-713		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	77	F						24								1		0	Normal aged brain 								PFC, Bag 21 or 40											
		NP12/155		NM-714		Control	Rare microscopic foci of metastatic tumour (midbrain, hippocampus, spinal cord) in otherwise normal aged brain.			Oxford Brain Bank	+	-	+	-	-	-	79	F						24								1		0	Rare microscopic foci of metastatic tumour (midbrain, hippocampus, spinal cord) in otherwise normal aged brain.								PFC, Bag 21 or 41											
		NP12/161		NM-715		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	69	M						48								1		0	Normal brain 								PFC, Slices 											
		NP13/011		NM-716		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	62	F						24								1		0	Normal brain 								PFC, Slices 											
		NP13/012		NM-717		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	60	F						48								1		0	Normal brain 								PFC, Slices 											
		NP13/017		NM-718		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	69	F						48								1		0	Normal brain 								PFC, Slices 											
		NP13/071		NM-719		MCI	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	83	F						24								1		0	Normal aged brain 								PFC, Bag 21 or 41											
		NP13/073		NM-720		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	59	M						24								1		0	Normal brain 								PFC, Slices 											
		NP13/096		NM-721		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	92	F						48								1		0	Normal aged brain 								PFC, Slices 											
		NP13/103		NM-722		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	48	F						48								1		0	Normal brain 								PFC, Slices 											
		NP13/109		NM-723		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	69	M						24								1		0	Normal aged brain 								PFC, Slices 											
		NP13/126		NM-724		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	56	M						48								1		0	Normal brain 								PFC, Slices 											
		NP13/127		NM-725		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	60	M						24								1		0	Normal brain 								PFC, Slices 											
		NP13/128		NM-726		Control	Normal brain			Oxford Brain Bank	+	-	+	-	-	-	68	M						48								1		0	Normal brain								PFC, Slices 											
		NP13/141		NM-727		Control	Normal brain 			Oxford Brain Bank	+	-	+	-	-	-	56	M						48								1		0	Normal brain 								PFC, Slices 											
		NP13/161		NM-728		Control	Control - Low Alzheimers disease (AD)			Oxford Brain Bank	+	-	+	-	-	-	73	M						44								1		0	Control - Low Alzheimers disease (AD)								PFC, Slices 											
		NP14/011		NM-729		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	93	F						24								1		0	Normal aged brain 								PFC, Slices 											
		NP14/150		NM-730		MCI	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	95	F						54								1		0	Normal aged brain 								PFC, Slices 											
		NP15/008		NM-731		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	87	F						36								1		0	Normal aged brain 								PFC, Slices 											
		NP15/080		NM-732		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	71	M						24								1		0	Normal aged brain 								PFC, Slices 											
		NP16/022		NM-733		Control	Normal brain for age 			Oxford Brain Bank	+	-	+	-	-	-	68	F						17								1		0	Normal brain for age 								PFC, Slices 											
		NP16/408		NM-734		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	70	M						42								1		0	Normal aged brain 								PFC, Slices 											
		NP16/427		NM-735		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	88	F						112								1		0	Normal aged brain 								Frozen frontal											
		NP17/100		NM-736		Control	Normal brain for age 			Oxford Brain Bank	+	-	+	-	-	-	55	M						18								1		0	Normal brain for age 								PFC, Slices 											
		NP17/102		NM-737		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	81	F						44								1		0	Normal aged brain 								PFC, Slices 											
		NP17/109		NM-738		Control	Normal aged brain 			Oxford Brain Bank	+	-	+	-	-	-	77	F						81								1		0	Normal aged brain 								PFC, Slices 											
		NP18/013		NM-739		Control	Normal aged  control 			Oxford Brain Bank	+	-	+	-	-	-	57	M						46								1		0	Normal aged  control 								PFC, Slices 											
		NP18/023		NM-740		Control	Normal brain for patients age 			Oxford Brain Bank	+	-	+	-	-	-	56	M						49								1		0	Normal brain for patients age 								PFC, Slices 											
		NP18/077		NM-741		Control	Normal aged  control 			Oxford Brain Bank	+	-	+	-	-	-	82	M						45								1		0	Normal aged  control 								PFC, Slices 											
		NP12/044		NM-742		PD	Atypical parkinsonism	Noted atypical and agressive with cognitive impairment		Oxford Brain Bank	+	-	+	-	-	-	73	F														1		0	Atypical parkinsonism								frontal cortex											
		NP12/114		NM-743		PDD	PDD			Oxford Brain Bank	+	-	+	-	-	-	79	M						96								1		0	PDD								PFC, Tube A 											
		NP12/139		NM-744		PD	" Parkinson‚Äôs disease 
-Cortical Lewy body pathology (common variant, modified McKeith stage: 
 ‚ÄúIntermediate‚Äù Alzheimer‚Äôs disease (AD) neuropathologic change (ABC score: A3, B2, C1 ), Braak III/IV
 Cerebral amyloid angiopathy (CAA)
-Small vessel disease / arteriolosclerosis
 Atherosclerosis, widespread, mild to moderate (described macroscopically)
Normal spinal cord
Diagnosis:

Pathology: 
1) Alpha synucleinopathy of Lewy body-type. See comment.
2) ‚ÄòIntermediate‚Äô Alzheimer‚Äôs disease neuropathologic change.
3) Vascular disease (atherosclerosis, arteriolosclerosis and cerebral amyloid angiopathy)."			Oxford Brain Bank	+	-	+	-	-	-	80	M						72								1		0	" Parkinson‚Äôs disease 
-Cortical Lewy body pathology (common variant, modified McKeith stage: 
 ‚ÄúIntermediate‚Äù Alzheimer‚Äôs disease (AD) neuropathologic change (ABC score: A3, B2, C1 ), Braak III/IV
 Cerebral amyloid angiopathy (CAA)
-Small vessel disease / arteriolosclerosis
 Atherosclerosis, widespread, mild to moderate (described macroscopically)
Normal spinal cord
Diagnosis:

Pathology: 
1) Alpha synucleinopathy of Lewy body-type. See comment.
2) ‚ÄòIntermediate‚Äô Alzheimer‚Äôs disease neuropathologic change.
3) Vascular disease (atherosclerosis, arteriolosclerosis and cerebral amyloid angiopathy)."								PFC, Tube C 											
		NP13/010		NM-745		PD	"  Parkinson‚Äôs disease (brainstem Lewy body pathology)
  Cortical Lewy body pathology (diffuse neocortical stage)
 Intermediate Alzheimer‚Äôs disease neuropathologic change (ABC score: A3:, B:2, C:1),
 Braak III/IV
Cerebral amyloid angiopathy
Mild small vessel pathology / arteriolosclerosis (likely age-related)
Hippocampal vasculopathy with fibrosis and calcification (VFC), incidental finding"			Oxford Brain Bank	+	-	+	-	-	-	94	M						24								1		0	"  Parkinson‚Äôs disease (brainstem Lewy body pathology)
  Cortical Lewy body pathology (diffuse neocortical stage)
 Intermediate Alzheimer‚Äôs disease neuropathologic change (ABC score: A3:, B:2, C:1),
 Braak III/IV
Cerebral amyloid angiopathy
Mild small vessel pathology / arteriolosclerosis (likely age-related)
Hippocampal vasculopathy with fibrosis and calcification (VFC), incidental finding"																			
		NP13/112		NM-746		PD	Parkinson's Disease 			Oxford Brain Bank	+	-	+	-	-	-	70	F						24								1		0	Parkinson's Disease 								PFC, Slices 											
		NP14/087		NM-747		PD	"1. Parkinson‚Äôs Disease
2. Cerebrovascular disease with:
a. atherosclerosis, mild-moderate;
b. arteriolarsclerosis, mild-moderate;
c. microinfarcts, rare."			Oxford Brain Bank	+	-	+	-	-	-	80	M						24								1		0	"1. Parkinson‚Äôs Disease
2. Cerebrovascular disease with:
a. atherosclerosis, mild-moderate;
b. arteriolarsclerosis, mild-moderate;
c. microinfarcts, rare."								PFC, Slices 											
		NP14/133		NM-748		PDD	"1. Parkinson's disease [neocortical].
2. Alzheimer disease neuropathologic changes A3, B2, CO."			Oxford Brain Bank	+	-	+	-	-	-	80	M						72								1		0	"1. Parkinson's disease [neocortical].
2. Alzheimer disease neuropathologic changes A3, B2, CO."								PFC, Slices 											
		NP15/013		NM-749		PD	1. Parkinson's disease [neocortical].			Oxford Brain Bank	+	-	+	-	-	-	79	M						72								1		0	1. Parkinson's disease [neocortical].								PFC, Slices 											
		NP17/021		NM-750		PDD	"1. Parkinson‚Äôs disease [Neocortical] with clinical history of dementia. 
Autopsy confirmed that clinical diagnosis of Parkinson‚Äôs disease. Only a low level of Alzhemier-related pathology. "			Oxford Brain Bank	+	-	+	-	-	-	69	M						72								1		0	"1. Parkinson‚Äôs disease [Neocortical] with clinical history of dementia. 
Autopsy confirmed that clinical diagnosis of Parkinson‚Äôs disease. Only a low level of Alzhemier-related pathology. "								PFC, Slices 											
		NP18/005		NM-751		PD	"1. Parkinson‚Äôs Disease [Limbic] 
2. Intermediate level of Alzheimer‚Äôs Disease neuropathologic change "			Oxford Brain Bank	+	-	+	-	-	-	78	M						24								1		0	"1. Parkinson‚Äôs Disease [Limbic] 
2. Intermediate level of Alzheimer‚Äôs Disease neuropathologic change "								PFC, Slices 											
		NP18/049		NM-752		Atypical PD, mitochondiral disease	"1. Clinical diagnosis of mitochondrial disease (mitochondrial DNA deletions due to PE01 gene mutation) 
2. Severe nigral degeneration without lewy bodies. 
The patient presented with progressive external ophthalmoplegia, ptosis, and mild parkinsonism and subsequently underwent multiple investigation leading to the diagnosis of a familial mitochondral disorder. Neuropathological examination showed severe substantia nigra neuronal loss but no lewy bodies. There were also some degenerative changes in cerebellar cortex, with loss of purkinje, and probably, granular neurons. It has been noted that movement disorders associated with mitochondrial disease may show paradoxical clinical-anatomic correlation's such that severe nigral degeneration may be found in individuals who had only mld or even no clinical signs of parkinsonism.,  "			Oxford Brain Bank	+	-	+	-	-	-	88	M						48								1		0	"1. Clinical diagnosis of mitochondrial disease (mitochondrial DNA deletions due to PE01 gene mutation) 
2. Severe nigral degeneration without lewy bodies. 
The patient presented with progressive external ophthalmoplegia, ptosis, and mild parkinsonism and subsequently underwent multiple investigation leading to the diagnosis of a familial mitochondral disorder. Neuropathological examination showed severe substantia nigra neuronal loss but no lewy bodies. There were also some degenerative changes in cerebellar cortex, with loss of purkinje, and probably, granular neurons. It has been noted that movement disorders associated with mitochondrial disease may show paradoxical clinical-anatomic correlation's such that severe nigral degeneration may be found in individuals who had only mld or even no clinical signs of parkinsonism.,  "								PFC, Slices 											
		NP08/087		NM-753		PD	PD	Text says: see comment, there is no comment		Oxford Brain Bank	+	-	+	-	-	-																1		0	PD								frontal tube											
		RI05/177		NM-754		PD	"PARKINSON‚ÄôS DISEASE (LEWY-BODY TYPE, BRAINSTEM PREDOMINANT)
COMMENT

Histological appearances are consistent with Parkinson‚Äôs disease of Lewy body-associated type. The pathology is almost completely confined to the brainstem with the exception of a very few probable Lewy bodies in the limbic cortex (cingulate). The cause of the mild reactive changes in the deep grey nuclei is not clear, but they are relatively acute and could be in keeping with the known pre-mortem trauma."			Oxford Brain Bank	+	-	+	-	-	-	37	M						48								1		0	"PARKINSON‚ÄôS DISEASE (LEWY-BODY TYPE, BRAINSTEM PREDOMINANT)
COMMENT

Histological appearances are consistent with Parkinson‚Äôs disease of Lewy body-associated type. The pathology is almost completely confined to the brainstem with the exception of a very few probable Lewy bodies in the limbic cortex (cingulate). The cause of the mild reactive changes in the deep grey nuclei is not clear, but they are relatively acute and could be in keeping with the known pre-mortem trauma."																			
		RI02/186		NM-755		PD	"1.  Parkinson's disease.                                   

2.  Atherosclerosis and arteriolarsclerosis, mild-moderate. 

Braak I/II CERAD Normal with regards to AD."			Oxford Brain Bank	+	-	+	-	-	-	77	M						72								1		0	"1.  Parkinson's disease.                                   

2.  Atherosclerosis and arteriolarsclerosis, mild-moderate. 

Braak I/II CERAD Normal with regards to AD."								PFC, BA9											
